Jean‐françois Bach

Jean‐françois Bach's AcademicInfluence.com Rankings

Jean‐françois Bach

Philosophy

#2200

World Rank

#3815

Historical Rank

Logic

#483

World Rank

#897

Historical Rank

philosophy Degrees

Jean‐françois Bach

Biology

#2437

World Rank

#3863

Historical Rank

Immunology

#84

World Rank

#90

Historical Rank

biology Degrees

Download Badge

Philosophy
Biology

Jean‐françois Bach's Degrees

Doctorate Medicine Université Paris Cité
PhD Immunology Université Paris Cité

Why Is Jean‐françois Bach Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Jean‐françois Bach's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

The effect of infections on susceptibility to autoimmune and allergic diseases. (2002) (2552)
Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia (1996) (1938)
The ‘hygiene hypothesis’ for autoimmune and allergic diseases: an update (2010) (1047)
Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes. (2005) (909)
Activation of natural killer T cells by α-galactosylceramide treatment prevents the onset and recurrence of autoimmune Type 1 diabetes (2001) (668)
Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. (1994) (655)
TGF-β-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes (2003) (649)
Strong clustering and stereotyped nature of Notch3 mutations in CADASIL patients (1997) (634)
Insulin-dependent diabetes mellitus as an autoimmune disease. (1994) (633)
Syngeneic transfer of autoimmune diabetes from diabetic NOD mice to healthy neonates. Requirement for both L3T4+ and Lyt-2+ T cells (1987) (625)
Truncating mutations in CCM1, encoding KRIT1, cause hereditary cavernous angiomas (1999) (457)
CYCLOSPORIN INCREASES THE RATE AND LENGTH OF REMISSIONS IN INSULIN-DEPENDENT DIABETES OF RECENT ONSET Results of a Multicentre Double-blind Trial (1986) (427)
Overexpression of Natural Killer T Cells Protects Vα14-Jα281 Transgenic Nonobese Diabetic Mice against Diabetes (1998) (425)
CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice. (1997) (408)
Early quantitative and functional deficiency of NK1+‐like thymocytes in the NOD mouse (1996) (408)
Insulin-dependent diabetes mellitus (IDDM) is associated with CTLA4 polymorphisms in multiple ethnic groups. (1997) (393)
Infections and autoimmune diseases. (2005) (345)
Serum thymulin in human zinc deficiency. (1988) (337)
Regulatory lymphocytes: Regulatory T cells under scrutiny (2003) (331)
Contribution of zinc and other metals to the biological activity of the serum thymic factor. (1982) (313)
Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. (1992) (303)
Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma. (1997) (301)
The hygiene hypothesis in autoimmunity: the role of pathogens and commensals (2017) (296)
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. (1991) (293)
Regulatory T cells under scrutiny (2003) (291)
IN VIVO CELL ACTIVATION FOLLOWING OKT3 ADMINISTRATION: SYSTEMIC CYTOKINE RELEASE AND MODULATION BY CORTICOSTEROIDS (1990) (289)
Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. (1982) (280)
Detection of circulating immune complexes in human sera by simplified assays with polyethylene glycol. (1977) (279)
T cell-mediated inhibition of the transfer of autoimmune diabetes in NOD mice (1989) (278)
ISOLATION, BIOCHEMICAL CHARACTERISTICS, AND BIOLOGICAL ACTIVITY OF A CIRCULATING THYMIC HORMONE IN THE MOUSE AND IN THE HUMAN (1975) (275)
Tolerance to islet autoantigens in type 1 diabetes. (2001) (263)
Cytokine‐related syndrome following injection of anti‐CD3 monoclonal antibody: Further evidence for transient in vivo T cell activation (1990) (260)
Probiotics Supplementation During Pregnancy or Infancy for the Prevention of Atopic Dermatitis: A Meta-analysis (2012) (260)
Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells. (2005) (256)
Systemic reaction to the anti-T-cell monoclonal antibody OKT3 in relation to serum levels of tumor necrosis factor and interferon-gamma [corrected]. (1989) (252)
Association of anti-β2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus☆ (1992) (248)
The mode of action of immunosuppressive agents. (1975) (237)
Sex steroids, glucocorticoids, stress and autoimmunity (1991) (237)
A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. (2004) (223)
Anti‐suppressor effect of cyclophosphamide on the development of spontaneous diabetes in nod mice (1988) (218)
A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes (2004) (215)
Adaptive TGF-β-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment (2007) (213)
DEFICIT OF SUPPRESSOR T CELLS IN ACTIVE MULTIPLE SCLEROSIS (1980) (206)
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with histological fibrosis and activity. (1999) (204)
Biochemical characterisation of a serum thymic factor (1977) (200)
Human in vivo antigenic modulation induced by the anti‐T cell OKT3 monoclonal antibody (1982) (196)
METABOLIC AND IMMUNOLOGICAL EFFECTS OF CYCLOSPORIN IN RECENTLY DIAGNOSED TYPE 1 DIABETES MELLITUS (1985) (192)
Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes (2015) (185)
Restriction of the human in vivo immune response against the mouse monoclonal antibody OKT3. (1986) (179)
Limited Duration of Remission of Insulin Dependency in Children With Recent Overt Type I Diabetes Treated With Low-Dose Cyclosporin (1990) (167)
Aberrant T cell-mediated immunity in untreated schizophrenic patients: deficient interleukin-2 production. (1989) (161)
IN VITRO ROSETTE INHIBITION BY ANTIHUMAN ANTILYMPHOCYTE SERUM: CORRELATION WITH SKIN GRAFT PROLONGATION IN SUBHUMAN PRIMATES (1969) (159)
Transfer of symptomatic peanut allergy to the recipient of a combined liver-and-kidney transplant. (1997) (154)
Treatment with Nonmitogenic Anti-CD3 Monoclonal Antibody Induces CD4+ T Cell Unresponsiveness and Functional Reversal of Established Experimental Autoimmune Encephalomyelitis1 (2005) (153)
Organ-specific autoimmunity. (1995) (151)
Neuroendocrine control of thymic hormonal production. I. Prolactin stimulates in vivo and in vitro the production of thymulin by human and murine thymic epithelial cells. (1989) (150)
Appearance of T-cell markers in bone marrow rosette-forming cells after incubation with thymosin, a thymic hormone. (1971) (148)
Growth hormone and insulin-like growth factor-I stimulate hormonal function and proliferation of thymic epithelial cells. (1992) (148)
Mature mainstream TCR alpha beta+CD4+ thymocytes expressing L-selectin mediate "active tolerance" in the nonobese diabetic mouse. (1998) (145)
Peanut agglutinin. I. A new tool for studying T lymphocyte subpopulations. (1978) (142)
Treatment with granulocyte colony-stimulating factor prevents diabetes in NOD mice by recruiting plasmacytoid dendritic cells and functional CD4(+)CD25(+) regulatory T-cells. (2005) (141)
Identification and mapping to chromosome 1 of a susceptibility locus for periinsulitis in non-obese diabetic mice (1991) (138)
Systemic Toll-Like Receptor Stimulation Suppresses Experimental Allergic Asthma and Autoimmune Diabetes in NOD Mice (2010) (134)
Acceleration of the onset of diabetes in NOD mice by thymectomy at weaning (1989) (132)
Jagged2-expressing hematopoietic progenitors promote regulatory T cell expansion in the periphery through notch signaling. (2006) (131)
Studies on thymus products. II. Demonstration and characterization of a circulating thymic hormone. (1973) (131)
Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. (1988) (130)
Peripheral microchimerism in long-term cadaveric-kidney allograft recipients (1994) (129)
Selective IgA deficiency and autoimmunity. (1992) (129)
Thymic abnormalities in fetuses aborted from human immunodeficiency virus type 1 seropositive women. (1992) (128)
Low plasma androgens in women with active or quiescent systemic lupus erythematosus. (1982) (128)
The use of monoclonal anti-T cell antibodies to study T cell imbalances in human diseases. (1981) (127)
Down-regulation of Fc alpha receptors on blood cells of IgA nephropathy patients: evidence for a negative regulatory role of serum IgA. (1998) (126)
Anti-titin antibodies in myasthenia gravis: tight association with thymoma and heterogeneity of nonthymoma patients. (2001) (124)
Influence of castration, alone or combined with thymectomy, on the development of diabetes in the nonobese diabetic mouse. (1991) (124)
Evaluation of T cell subsets in myasthenia gravis using anti-T cell monoclonal antibodies. (1981) (123)
The hygiene hypothesis: an explanation for the increased frequency of insulin-dependent diabetes. (2012) (123)
G-CSF Therapy of Ongoing Experimental Allergic Encephalomyelitis Via Chemokine- and Cytokine-Based Immune Deviation (2002) (122)
Thymic hormone-containing cells. Characterization and localization of serum thymic factor in young mouse thymus studied by monoclonal antibodies (1982) (122)
Notch3 Mutations in Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CADASIL), a Mendelian Condition Causing Stroke and Vascular Dementia (1997) (120)
10-year educational programme aimed at rheumatic fever in two French Caribbean islands (1996) (119)
Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases (2003) (118)
A gene for hereditary paroxysmal cerebellar ataxia maps to chromosome 19p (1995) (117)
Studies on thymus products. IV. Absence of serum 'thymic activity' in adult NZB and (NZB x NZW) F1 mice. (1973) (117)
CD8+ T cell homing to the pancreas in the nonobese diabetic mouse is CD4+ T cell-dependent. (1991) (114)
Unique role of CD4+CD62L+ regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice (2004) (113)
Pet exposure and risk of atopic dermatitis at the pediatric age: a meta-analysis of birth cohort studies. (2013) (111)
Prophylactic use of OKT3 monoclonal antibody in cadaver kidney recipients. Utilization of OKT3 as the sole immunosuppressive agent. (1986) (111)
Evidence for a serum-factor secreted by the human thymus. (1972) (111)
Presence of preactivated T cells in hemodialyzed patients: their possible role in altered immunity. (1986) (109)
Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. (1982) (107)
In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients. (1989) (106)
Genetic and physical mapping of a type 1 diabetes susceptibility gene (IDDM12) to a 100-kb phagemid artificial chromosome clone containing D2S72-CTLA4-D2S105 on chromosome 2q33. (2000) (106)
Antigen recognition by T lymphocytes. Thymus and marrow dependence of spontaneous rosette forming cells in the mouse. (1972) (105)
Systemic lupus erythematosus. Morphologic correlations with immunologic and clinical data at the time of biopsy. (1978) (105)
Adoptive T cell transfer of autoimmune nonobese diabetic mouse diabetes does not require recruitment of host B lymphocytes. (1988) (102)
A monoclonal anti-DNA antibody also binds to cell-surface protein(s). (1984) (102)
Genetic analysis of immune dysfunction in non‐obese diabetic (NOD) mice: Mapping of a susceptibility locus close to the Bcl‐2 gene correlates with increased resistance of NOD T cells to apoptosis induction (1994) (102)
Corticosteroid inhibition of the OKT3-induced cytokine-related syndrome--dosage and kinetics prerequisites. (1991) (102)
Differential in situ expression of cytokines in renal allograft rejection. (1991) (100)
HLA class II DNA polymorphism in a Moroccan population from the Souss, Agadir area. (1998) (96)
Are there unique autoantigens triggering autoimmune diseases? (1998) (96)
Insulin-dependent diabetes mellitus as a beta-cell targeted disease of immunoregulation. (1995) (96)
Binding of a monoclonal anti-DNA autoantibody to identical protein(s) present at the surface of several human cell types involved in lupus pathogenesis. (1985) (95)
The human immune response to the OKT3 monoclonal antibody is oligoclonal. (1986) (94)
Defective Fc gamma RII gene expression in macrophages of NOD mice: genetic linkage with up-regulation of IgG1 and IgG2b in serum. (1996) (93)
Protective role of infections and vaccinations on autoimmune diseases. (2001) (92)
Structural study of circulating thymic factor: a peptide isolated from pig serum. I. Isolation and purification. (1977) (88)
Hepatitis B virus DNA in mononuclear blood cells. A frequent event in hepatitis B surface antigen-positive and -negative patients with acute and chronic liver disease. (1986) (88)
In vivo Specific Antigen Recognition by Rosette Forming Cells (1970) (87)
Anti‐α/β T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice (1991) (87)
Pancreatic islet beta cells drive T cell-immune responses in the nonobese diabetic mouse model (1995) (86)
Structural study of circulating thymic factor: a peptide isolated from pig serum. II. Amino acid sequence. (1977) (85)
Analysis of circulating IgA and detection of immune complexes in primary IgA nephropathy. (1982) (85)
Distinct HLA class II alleles determine antibody response to vaccination with hepatitis B surface antigen. (1998) (83)
The multi-faceted zinc dependency of the immune system. (1981) (83)
Anti-tumor necrosis factor modulates anti-CD3-triggered T cell cytokine gene expression in vivo. (1994) (82)
Neonatal myasthenia gravis (1988) (81)
Anti‐AChR antibodies, thymic histology, and T cell subsets in myasthenia gravis (1984) (81)
Studies on thymus products. 3. Epithelial origin of the serum thymic factor. (1974) (81)
Antigenic modulation - a major mechanism of antibody action. (1984) (80)
Binding of nucleosomes to a cell surface receptor: Redistribution and endocytosis in the presence of lupus antibodies (1996) (80)
Protection from insulin‐dependent diabetes mellitus is linked to a peptide transporter gene (1993) (79)
Association of neonatal myasthenia gravis with antibodies against the fetal acetylcholine receptor (1994) (79)
Unusual phenotypes of human inducer T cells as measured by OKT4 and related monoclonal antibodies. (1981) (78)
Involvement of human muscle acetylcholine receptor alpha-subunit gene (CHRNA) in susceptibility to myasthenia gravis. (1994) (78)
Transforming Growth Factor-β and Natural Killer T-Cells Are Involved in the Protective Effect of a Bacterial Extract on Type 1 Diabetes (2006) (78)
Transient Epstein-Barr virus reactivation in CD3 monoclonal antibody-treated patients. (2010) (77)
Thymic epithelium in AIDS. An immunohistologic study. (1986) (76)
Identification and functional activity of prolactin receptors in thymic epithelial cells. (1991) (75)
IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse. (1996) (75)
One-month prophylactic use of OKT3 in cadaver kidney transplant recipients. (1988) (74)
Immunological effects of high dose administration of anti-CD4 antibody in rheumatoid arthritis patients. (1991) (74)
EVIDENCE THAT ANTIHUMAN TUMOR NECROSIS FACTOR MONOCLONAL ANTIBODY PREVENTS OKT3‐INDUCED ACUTE SYNDROME (1992) (74)
Marked reduction of DNA antibody production and glomerulopathy in thymulin (FTS-Zn) or cyclosporin A treated (NZB X NZW) F1 mice. (1983) (73)
Detection of humoral and cell-mediated immunity to kidney basement membranes in human renal diseases. (1972) (73)
Cyclosporine delays but does not prevent clinical onset in glucose intolerant pre-type 1 diabetic children. (1996) (72)
Mechanisms of autoimmunity in insulin-dependent diabetes mellitus. (1988) (72)
Evaluation of antibodies, antigens and immune complexes present in antilymphocyte serum. (1976) (72)
Acute HIV infection after acupuncture treatments. (1989) (71)
Treatment of recalcitrant plaque psoriasis with a humanized non-depleting antibody to CD4. (1998) (70)
REGULATION OF θ‐ANTIGEN EXPRESSION BY AGENTS ALTERING CYCLIC AMP LEVEL AND BY THYMIC FACTOR (1975) (67)
Absence of functional relevance of human transporter associated with antigen processing polymorphism for peptide selection. (1997) (67)
A zinc-dependent epitope on the molecule of thymulin, a thymic hormone. (1985) (66)
Effects of cyclosporine in severe systemic lupus erythematosus. (1987) (66)
Transforming growth factor‐β and T‐cell‐mediated immunoregulation in the control of autoimmune diabetes (2006) (66)
The Fetal/Adult Acetylcholine Receptor Antibody Ratio in Mothers with Myasthenia Gravis as a Marker for Transfer of the Disease to the Newborn (1997) (64)
Antigen recognition by T lymphocytes. II. Similar effects of azathioprine, antilymphocyte serum, and anti-theta serum on rosette-forming lymphocytes in normal and neonatally thymectomized mice. (1972) (64)
HLA antigen in three types of glomerulonephritis. (1978) (64)
Identification of genomic typing of non-DR3 HLA class II genes associated with myasthenia gravis (1993) (64)
Binding of autologous erythrocytes to immature T-cells. (1975) (63)
Plasma C-Peptide Levels and Clinical Remissions in Recent-Onset Type I Diabetic Patients Treated With Cyclosporin A and Insulin (1990) (62)
Reduction of morbidity and cytokine release in anti-CD3 MoAb-treated mice by corticosteroids. (1990) (62)
Passive immunotherapy in AIDS: a randomized trial of serial human immunodeficiency virus-positive transfusions of plasma rich in p24 antibodies versus transfusions of seronegative plasma. (1992) (62)
POEMS syndrome presenting as systemic sclerosis. Clinical and pathologic study of a case with microangiopathic glomerular lesions. (1988) (62)
No Major Role for the CTLA-4 Gene in the Association of Autoimmune Thyroid Disease With IDDM (1998) (62)
The NOD mouse. (1997) (61)
Thymic Factors (Part 1 of 2) (1976) (61)
Hormonal modulation in systemic lupus erythematosus. Preliminary clinical and hormonal results with cyproterone acetate. (1985) (60)
In vitro culture of functional human thymic epithelium. (1975) (60)
Syngeneic t cell transfer of diabetes into nod newborn mice: in situ studies of the autoimmune steps leading to insulin‐producing cell destruction (1989) (60)
IMPROVEMENT OF CELLULAR IMMUNITY AND IgA PRODUCTION IN IMMUNODEFICIENT CHILDREN AFTER TREATMENT WITH SYNTHETIC SERUM THYMIC FACTOR (FTS) (1982) (59)
Low serum thymic hormone levels in patients with acquired immunodeficiency syndrome. (1983) (59)
Granulocyte-colony stimulating factor treatment of lupus autoimmune disease in MRL-lpr/lpr mice. (1999) (59)
IL-7 up-regulates IL-4 production by splenic NK1.1+ and NK1.1- MHC class I-like/CD1-dependent CD4+ T cells. (1999) (59)
Peripherin: an islet antigen that is cross-reactive with nonobese diabetic mouse class II gene products. (1992) (59)
Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation. (1995) (59)
IMPLICATIONS OF DE NOVO ELAM‐1 AND VCAM‐1 EXPRESSION IN HUMAN CARDIAC ALLOGRAFT REJECTION (1993) (57)
Resistance of T-cells to apoptosis in autoimmune diabetic (NOD) mice is increased early in life and is associated with dysregulated expression of Bcl-x (1998) (57)
Early effect of adult thymectomy. (1971) (56)
Studies on the thymus in nonobese diabetic mouse. I. Changes in the microenvironmental compartments. (1991) (56)
SELF AND NOT-SELF (1974) (56)
Founder effect in GLC1A-linked familial open-angle glaucoma in Northern France. (1998) (55)
Anti-CD3 antibodies for type 1 diabetes: beyond expectations (2011) (55)
Fate of circulating immune complexes in infective endocarditis. (1979) (55)
A Subset of NKT Cells That Lacks the NK1.1 Marker, Expresses CD1d Molecules, and Autopresents the α-Galactosylceramide Antigen1 (2000) (55)
Specific receptors for the serum thymic factor (FTS) in lymphoblastoid cultured cell lines. (1980) (54)
Thymus dependency of rosette-forming cells: evidence for a circulating thymic hormone. (1972) (54)
In vivo and in vitro studies of thymulin in marginally zinc‐deficient mice (1984) (54)
Immunosuppressive therapy of autoimmune diseases. (1993) (54)
Autoimmune Diseases as the Loss of Active “Self‐Control” (2003) (53)
Human CD3 Transgenic Mice: Preclinical Testing of Antibodies Promoting Immune Tolerance (2011) (53)
Six questions about the hygiene hypothesis. (2005) (52)
The elusive case for a role of mimicry in autoimmune diseases. (2004) (52)
THE METABOLISM OF AZATHIOPRINE IN RENAL FAILURE (1971) (51)
Cascade modulation by anti‐tumor necrosis factor monoclonal antibody of interferon‐γ, interleukin 3 and interleukin 6 release after triggering of the CD33/T cell receptor activation pathway (1991) (50)
Induction of differentiation in human marrow T cell precursors by the synthetic serum thymic factor, FTS. (1980) (50)
Characterization of the Extracellular Matrix—Containing Giant Perivascular Spaces in the NOD Mouse Thymus (1993) (49)
Studies on the zinc binding site to the serum thymic factor. (1984) (49)
Characterization of facteur thymique sérique (FTS) in the thymus. I. Fixation of anti-FTS antibodies on thymic reticulo-epithelial cells. (1980) (49)
Regulatory T Cells in the Control of Autoimmune Diabetes: The Case of the NOD Mouse (2005) (49)
The OKT3 immunosuppressive effect. In situ antigenic modulation of human graft-infiltrating T cells. (1990) (49)
Autoantibodies associated with acute rejection after liver transplantation for type-2 autoimmune hepatitis. (2000) (48)
The anti-CD3-induced syndrome: a consequence of massive in vivo cell activation. (1991) (48)
Cytoplasmic localization of FTS (facteur thymique sérique) in thymic epithelial cells. An immunoelectronmicroscopical study. (1980) (48)
Increased incidence of inflammatory bowel disease: the price of the decline of infectious burden? (2004) (47)
Studies on thymus products. I. Modification of rosette-forming cells by thymic extracts. Determination of the target RFC sub-population. (1973) (47)
Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. (1996) (47)
Thymomatous epithelial cells and skeletal muscle share a common epitope defined by a monoclonal antibody. (1987) (46)
Thymic hormone containing cells. III. Evidence for a feed-back regulation of the secretion of the serum thymic factor (FTS) by thymic epithelial cells. (1983) (46)
Activities of immunosuppressive agents in vitro. II. Different timing of azathioprine and methotrexate in inhibition and stimulation of mixed lymphocyte reaction. (1972) (45)
LUPUS ANTICOAGULANT AND THROMBOSIS IN SYSTEMIC LUPUS ERYTHEMATOSUS (1984) (45)
Long-Term Reversal of Established Autoimmunity upon Transient Blockade of the LFA-1/Intercellular Adhesion Molecule-1 Pathway1 (2002) (45)
Transforming growth factor-beta and natural killer T-cells are involved in the protective effect of a bacterial extract on type 1 diabetes. (2006) (45)
Molecular analysis of TCR junctional variability in individual infiltrated islets of non-obese diabetic mice: evidence for the constitution of largely autonomous T cell foci within the same pancreas. (1995) (44)
Hepatitis B antigen-associated periarteritis nodosa in patients undergoing long-term hemodialysis. (1980) (44)
Advances in Nephrology (1999) (44)
The Role of Innate Immunity in Autoimmunity (2004) (44)
Predictive medicine in autoimmune diseases: from the identification of genetic predisposition and environmental influence to precocious immunotherapy. (1994) (44)
Imbalance in T cell subsets in human diseases. (1981) (44)
Thymic hormone activity and spontaneous autoimmunity in dwarf mice and their littermates. (1976) (44)
Adult thymectomy promotes the manifestation of autoreactive lymphocytes. (1977) (44)
Thymic hormone-containing cells. VII. Adrenals and gonads control the in vivo secretion of thymulin and its plasmatic inhibitor. (1986) (43)
Effect of cyclosporin A treatment on the production of antibody in insulin-dependent (type I) diabetic patients. (1987) (43)
Nucleosomes inhibit phagocytosis of apoptotic thymocytes by peritoneal macrophages from MRL+/+ lupus‐prone mice (1998) (43)
Thymic dysfunction in the mutant diabetic (db/db) mouse. (1983) (43)
Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes. Absence of TAP2 contribution to association with insulin-dependent diabetes mellitus. (1995) (43)
Genetic heterogeneity of primary open angle glaucoma and ocular hypertension: linkage to GLC1A associated with an increased risk of severe glaucomatous optic neuropathy. (1997) (42)
Early weaning is beneficial to prevent atopic dermatitis occurrence in young children (2016) (42)
Key Role of the GITR/GITRLigand Pathway in the Development of Murine Autoimmune Diabetes: A Potential Therapeutic Target (2009) (42)
Diagnostic value of anti-nucleosome antibodies in the assessment of disease activity of systemic lupus erythematosus: a prospective study comparing anti-nucleosome with anti-dsDNA antibodies. (2006) (42)
Development of systemic lupus erythematosus after thymectomy for myasthenia gravis. Studies of suppressor cell function. (1981) (41)
Immunoregulatory Pathways Controlling Progression of Autoimmunity in NOD Mice (2008) (41)
The Activity of Immunoregulatory T Cells Mediating Active Tolerance Is Potentiated in Nonobese Diabetic Mice by an IL-4-Based Retroviral Gene Therapy1 (2001) (39)
Insulin autoantibodies in non-obese diabetic (NOD) mice. (1989) (39)
Antigen recognition by T lymphocytes. 3. Evidence for two populations of thymus-dependent rosette-forming cells in spleen and lymph nodes. (1973) (38)
Monoclonal antibodies and peptide therapy in autoimmune diseases (1993) (38)
The in vitro migration of murine fetal liver cells to thymic rudiments (1979) (38)
Thymic hormone containing cells. II. Evolution of cells containing the serum thymic factor (FTS or thymulin) in normal and autoimmune mice, as revealed by anti-FTS monoclonal antibodies. Relationship with Ia bearing cells. (1983) (37)
Evidence for the presence of immunoreactive acetylcholine receptors on human thymus cells (1984) (37)
Modulation of thymic endocrine function by thyroid and steroid hormones. (1988) (37)
Pathogenic autoantibodies. (1989) (37)
Heterogeneity of antibodies directed against the α-bungarotoxin binding site on human acetylcholine receptor and severity of myasthenia gravis (1986) (36)
In vivo blockade of the Fas-Fas ligand pathway inhibits cyclophosphamide-induced diabetes in NOD mice. (2001) (36)
Benzodiazepine anethesia in humans modulates the interleukin-1β, tumor necrosis factor-α and interleukin-6 responses of blood monocytes (1991) (36)
Relationships between antibodies to native DNA and glomerulonephritis in systemic lupus erythematosus. (1977) (36)
Microchimerism frequency two to thirty years after cadaveric kidney transplantation. (1994) (36)
Characterization of facteur thymique sérique (FTS) in the thymus. II. Direct demonstration of the presence of FTS in thymosin fraction V. (1980) (35)
PREDICTION OF SUCCESSFUL ALLOGRAFT REJECTION RETREATMENT WITH OKT31,2 (1992) (35)
Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus. (1992) (35)
Human systemic lupus erythematosus sera contain antibodies against cell-surface protein(s) that share(s) epitope(s) with DNA. (1986) (35)
The VH gene sequences of anti‐DNA antibodies in two different strains of lupus‐prone mice are highly related (1989) (35)
Unusually restricted anti‐isotype human immune response to OKT3 monoclonal antibody (1984) (35)
A historical view from thirty eventful years of immunotherapy in autoimmune diabetes. (2011) (35)
Association of the AChRalpha-subunit gene (CHRNA), DQA1*0101, and the DR3 haplotype in myasthenia gravis. Evidence for a three-gene disease model in a subgroup of patients. (1997) (34)
Anti-histone antibodies in schizophrenia and affective disorders (1988) (34)
On the Mechanisms of the Protective Effect of Infections on Type 1 Diabetes (2004) (34)
[Infections and autoimmunity]. (2005) (34)
Age-dependent penetrance and mapping of the locus for juvenile and early-onset open-angle glaucoma on chromosome 1q (GLC1A) in a French family (1996) (34)
Impaired Fcα receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients (1995) (34)
Evidence of the presence in normal serum of a carrier of the serum thymic factor (FTS) (1980) (34)
Thymulin, a zinc-dependent hormone (1989) (34)
Immunotherapy of insulin-dependent diabetes mellitus. (2001) (34)
A new radioimmunoassay for the thymic peptide thymulin, and its application for measuring thymulin in blood samples. (1990) (34)
Distribution of HLA class II alleles and haplotypes in insulin-dependent Moroccan diabetics. (1996) (34)
Intrastrain recurrent idiotypes among anti‐DNA antibodies of (NZB X NZW)F1 hybrid mice (1982) (34)
Anti-islet Cellular and Humoral Immunity, T-Cell Subsets, and Thymic Function in Type I Diabetes (1985) (34)
Anti-acetylcholine receptor antibodies in neonatal myasthenia gravis: heterogeneity and pathogenic significance. (1991) (33)
Insulin-dependent diabetes mellitus. (1991) (33)
Monoclonal antibody against the serum thymic factor (FTS). (1982) (33)
Thymoma epithelial cells secrete thymic hormone but do not express class II antigens of the major histocompatibility complex. (1985) (33)
Neonatal myasthenia gravis Anti-acetylcholine receptor antibodies in the amniotic fluid (1984) (33)
Contribution of DRB1*04 variants to predisposition to or protection from insulin dependent diabetes mellitus is independent of dq. (1996) (33)
Cyclosporine in autoimmune diseases. (1989) (32)
Production of anti-thymulin (FTS) monoclonal antibodies by immunization against human thymic epithelial cells. (1984) (32)
Immune regulation by characterized polypeptides (1987) (32)
Binding of a murine monoclonal anti‐DNA antibody to Raji cells. Implications for the interpretation of the Raji cell assay for immune complexes (1984) (32)
Mutations in HFE, the Hemochromatosis Candidate Gene, in Patients With NIDDM (1998) (31)
Adaptive human regulatory T cells: myth or reality? (2006) (31)
Cortical thymocyte differentiation in thymomas: an immunohistologic analysis of the pathologic microenvironment. (1987) (31)
Feedback regulation of the secretion of a thymic hormone (thymulin) by human thymic epithelial cells in culture. (1986) (30)
An enzyme immunoassay for synthetic thymulin. (1987) (30)
Selective action of azathioprine on T cells. (1973) (30)
Antithymocyte globulin in cadaver kidney transplantation: a randomized trial based on T-cell monitoring. (1981) (30)
The nonobese diabetic mouse model. Independent expression of humoral and cell-mediated autoimmune features. (1990) (30)
Evidence for an antigen-driven selection process in human autoantibodies against acetylcholine receptor. (1995) (29)
Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases (2002) (29)
The rheumatoid rosette. A diagnostic test unifying seropositive and seronegative rheumatoid arthritis. (1970) (29)
Selective depression of the xenogeneic cell-mediated lympholysis in systemic lupus erythematosus. (1979) (29)
Thymus hormones do not induce proliferative ability or cytolytic function in PNA+ cortical thymocytes. (1985) (29)
Anti-TNF abrogates the cytokine-related anti-CD3 induced syndrome. (1991) (29)
Xenotransplantation: baboons as potential liver donors? Scientific and ethical issues. (1993) (29)
T-cell subsets in multiple sclerosis: a comparative study between cell surface antigens and function. (1984) (29)
THE MODE OF ACTION OF THYMIC HORMONES (1979) (29)
Immunologic monitoring of Orthoclone OKT3-treated patients: the problem of antimonoclonal immune response. (1987) (29)
99th Dahlem Conference on Infection, Inflammation and Chronic Inflammatory Disorders: Immune therapies of type 1 diabetes: new opportunities based on the hygiene hypothesis (2010) (29)
The role of circulating immune complexes in the glomerular disease of experimental hepatosplenic schistosomiasis. (1979) (28)
A new in vitro test evaluating anti-lymphocyte serum potency. (1969) (28)
Mechanisms of Disease THE EFFECT OF INFECTIONS ON SUSCEPTIBILITY TO AUTOIMMUNE AND ALLERGIC DISEASES (2005) (28)
The effects of steroids on T cells. (1975) (27)
The kidney in cyclosporin A-treated diabetic patients: a long-term clinicopathological study. (1994) (27)
Extensive study of DRB, DQA, and DQB gene polymorphism in 23 DR2-positive, insulin-dependent diabetes mellitus patients. (1992) (27)
Intravenous γ-globulin in myasthenia gravis: Interaction with anti-acetylcholine receptor autoantibodies (1991) (27)
HIV predominantly induces IL-1 receptor antagonist over IL-1 synthesis in human primary monocytes. (1995) (27)
Interest in and limitations of monoclonal anti-T-cell antibodies for the follow-up of renal transplant patients. (1983) (27)
The contribution of cyclosporine A to the understanding and treatment of autoimmune diseases. (1999) (26)
Stimulation of prostaglandin synthesis by the serum factor (FTS). (1982) (26)
Lupus Nephropathy and Pregnancy: Report of 104 Cases in 36 Patients (1983) (26)
Anti-Bovine Serum Albumin Antibodies: Genetic Heterogeneity and Clinical Relevance in Adult-Onset IDDM (1995) (26)
Neonatal induction of allogeneic tolerance prevents T cell‐mediated autoimmunity in NOD mice (1989) (26)
T cell imbalance in nonleukemic and leukemic cutaneous lymphoma defined by monoclonal antibodies. (1981) (25)
Recombinational and physical mapping of the locus for primary open-angle glaucoma (GLC1A) on chromosome 1q23-q25. (1997) (25)
CD3 antibodies as unique tools to restore self-tolerance in established autoimmunity their mode of action and clinical application in type 1 diabetes. (2008) (25)
Studies on mouse autoreactive cells. I. Role of H-2 antigens in mouse autologous rosette formation. (1980) (25)
Early anti‐nucleosome autoantibodies from a single MRL +/+ mouse: fine specificity, V gene structure and pathogenicity (1998) (25)
Immunological studies in human ageing. I. In vitro functions of T cells and polymorphs. (1981) (25)
Further developments of the rosette inhibition test for the testing of antihuman lymphocyte serum. (1971) (25)
Alterations in thymocyte surface markers after in vivo treatment by serum thymic factor. (1978) (25)
Correlation between mixed lymphocyte culture performed before renal transplantation and kidney function. (1970) (24)
Demonstration of a circulating thymic hormone in mouse and in man. (1973) (24)
Autoimmunity and Type I Diabetes (1997) (24)
N-terminus cleavage of bcl-2 by a novel cellular non-ICE cysteine proteinase (1998) (24)
Concomitant early appearance of anti-ribonucleoprotein and anti-nucleosome antibodies in lupus prone mice. (2003) (24)
Clinical Use of OKT3: The Role of Cytokine Release and Xenosensitization (1988) (24)
HLA antigens in 88 cases of rheumatic fever observed in Martinique. (2008) (24)
[Myasthenia and pregnancy: a clinical and immunologic study of 42 cases (21 neonatal myasthenia cases)]. (1989) (24)
Mature Mainstream TCRαβ+CD4+ Thymocytes Expressing L-Selectin Mediate “Active Tolerance” in the Nonobese Diabetic Mouse (1998) (24)
The contribution of non-MHC genes to susceptibility to autoimmune diseases. (1991) (24)
Anchored polymerase chain reaction based analysis of the Vβ repertoire in the non‐obese diabetic (NOD) mouse (1994) (23)
The prevalence of selective IgA deficiency in type 1 diabetes mellitus (1992) (23)
Early defect of immunoregulatory T cells in autoimmune diabetes. (1996) (23)
ONE‐MONTH PROPHYLACTIC USE OF OKT3 IN CADAVER KIDNEY TRANSPLANT RECIPIENTS (1988) (23)
Role of CD4+CD45RA+ T cells in the development of autoimmune diabetes in the non-obese diabetic (NOD) mouse. (1993) (23)
T-cell antigenic sites involved in myasthenia gravis: correlations with antibody titre and disease severity. (1991) (23)
A Toll-like trigger for autoimmune disease (2005) (23)
The immunogenetics of myasthenia gravis, multiple sclerosis and their animal models (1993) (23)
Young age and HLA markers enhance the risk of progression to type 1 diabetes in antibody-positive siblings of diabetic children. (1998) (23)
Long-term complications of conventional immunosuppressive treatment. (1989) (23)
[Remission of established disease in diabetic NOD mice induced by anti-CD3 monoclonal antibody]. (1992) (23)
Comparative immunoreactivity of anti-trifluoroacetyl (TFA) antibody and anti-lipoic acid antibody in primary biliary cirrhosis: searching for a mimic. (2000) (23)
NMR study of a lymphocyte differentiating thymic factor. An investigation of the Zn(II)-nonapeptide complexes (thymulin). (1988) (23)
Anti-alpha/beta T cell receptor monoclonal antibody provides an efficient therapy for autoimmune diabetes in nonobese diabetic (NOD) mice. (1991) (22)
Antigen recognition by T lymphocytes. IV. Differences in antigen-binding characteristics of T- and B-RFC: a cause for variations in the evaluation of T-RFC. (1973) (22)
Immune lysis of hepatocytes in culture: accurate detection by aspartate aminotransferase release measurement. (1984) (22)
Altered cell-surface protein(s), crossreactive with DNA, on spleen cells of autoimmune lupic mice. (1987) (22)
Antagonistic analogue of Serum Thymic Factor (FTS) interacting with the FTS cellular receptor (1979) (22)
Identification of mimicry peptides based on sequential motifs of epitopes derived from 65‐kDa glutamic acid decarboxylase (1998) (22)
Regulation of contact sensitivity to DNFB in the mouse: effects of adult thymectomy and thymic factor. (1979) (21)
HLA genetic heterogeneity of hepatitis B vaccine response in hemodialyzed patients. (1993) (21)
Immunosuppressive therapy of autoimmune diseases. (1993) (21)
Nonneoplastic circulating sézary‐like cells in cutaneous T‐cell lymphoma. Ultrastructural, immunologic, and T‐cell receptor gene‐rearrangement studies (1987) (21)
The wasted mutant mouse. I. An animal model of secretory IgA deficiency with normal serum IgA. (1985) (21)
Evidence of CD4 + regulatory T cells in the non-obese diabetic male mouse (1994) (21)
Revisiting the Hygiene Hypothesis in the Context of Autoimmunity (2021) (21)
Factors predictive of cyclosporine-induced nephrotoxicity: the role of cyclosporine blood levels. (1990) (21)
Safety and efficacy of therapeutic monoclonal antibodies in clinical therapy. (1993) (21)
Presence of antibodies against a cell-surface protein, cross-reactive with DNA, in systemic lupus erythematosus: a marker of the disease. (1987) (21)
Autoimmune diabetes: how many steps for one disease? (1997) (20)
Casein‐specific IL‐4‐ and IL‐13‐secreting T cells: a tool to implement diagnosis of cow's milk allergy (2014) (20)
Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study (2017) (20)
Serum immunosuppressive activity of azathioprine in normal subjects and patients with liver diseases. (1972) (20)
The effect of immunosuppressive agents on T-cell subsets, as evaluated by use of monoclonal anti-T-cell antibodies. (1981) (19)
Activities of immunosuppressive agents in vitro. I. Rosette inhibition by azathioprine. (1971) (19)
Aberrant Function and Long-Term Survival of Mouse β Cells Exposed In Vitro to High Glucose Concentrations (1994) (19)
Quantification of circulating house dust mite‐specific IL‐4‐ and IL‐13‐secreting T cells correlates with rhinitis severity in asthmatic children and varies with the seasons (2014) (19)
Clinical Aspects of Thymulin (FTS) (1984) (19)
The suppressive effect of a supernate from concanavalin A-activated human lymphocytes: effects of concanavalin A-activated lymphocytes and their supernates on cytotoxic and mixed lymphocyte reactions. (1979) (19)
Depletion of helper/inducer T cells after thymectomy in myasthenic patients. (1983) (19)
In vitro inhibition of prostaglandin production by azathioprine and 6-mercaptopurine. (1988) (19)
Therapeutic Use of a Selective S1P1 Receptor Modulator Ponesimod in Autoimmune Diabetes (2013) (19)
A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection. (1989) (18)
Latent hepatitis B virus (HBV) infection in systemic necrotizing vasculitis. (1991) (18)
Alpha-bungarotoxin blocking antibodies in neonatal myasthenia gravis: frequency and selectivity (1989) (18)
Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection. (1998) (18)
Determination of DNA antibodies in normal and pathological sera by a new counterimmunoelectrophoresis method. (1976) (18)
Thymus Dependency of Rosette-Forming Cells (1973) (18)
Characterization of histamine H1 binding sites on human T lymphocytes by means of 125I-iodobolpyramine. Preferential expression of H1 receptors on CD8 T lymphocytes. (1990) (18)
Molecular and genetic characteristics of pathogenic autoantibodies. (1989) (17)
Murine monoclonal anti-DNA antibodies with an absolute specificity for DNA have a large amount of idiotypic diversity. (1983) (17)
Experimental models of type-I diabetes. (1986) (17)
Absence of clinical symptoms following the first injection of anti-T cell receptor monoclonal antibody (BMA 031) despite isolated TNF release. (1993) (17)
Absence of primary association between DM gene polymorphism and insulin-dependent diabetes mellitus or celiac disease. (1996) (17)
Protective effect of myasthenic immunoglobulins against the lethal toxicity of alpha bungarotoxin. (1987) (17)
Juvenile autoimmune diabetes: A pathogenic role for maternal antibodies? (2002) (17)
HLA-A1, B8-phenotype association and HBs antigenemia evolution in 440 hemodialyzed patients. (1977) (17)
Control of diabetes in NOD mice by suppressor cells. (1990) (17)
Benzodiazepine anesthesia in humans modulates the interleukin-1 beta, tumor necrosis factor-alpha and interleukin-6 responses of blood monocytes. (1991) (17)
The cytosolic free calcium in anti‐μ‐stimulated human B cells is derived partly from extracellular medium and partly from intracellular stores (1987) (17)
Healthy monozygous twins do not recognize identical T cell epitopes on the myelin basic protein autoantigen (1994) (16)
Fine specificity of antibodies produced in rhesus monkeys following in vivo treatment with anti‐T cell murine monoclonal antibodies (1986) (16)
Studies on thymus products. V. Influence of genetic selection based on antibody production on thymus hormone production. (1974) (16)
Increase in plasma 5α-androstane-3α,17β-diol glucuronide as a marker of peripheral androgen action in hirsutism: A side-effect induced by cyclosporine a (1990) (16)
Thymic factors. (1976) (16)
Neuroendocrine control of thymic hormonal production. II. Stimulatory effects of endogenous opioids on thymulin production by cultured human and murine thymic epithelial cells. (1990) (16)
Circulating thymic factor, facteur thymique serique (FTS), in mycosis fungoides and Sezary syndrome. (1979) (16)
Normal renal function 8 to 13 years after Cyclosporin A therapy in 285 diabetic patients (2002) (16)
Cellular and molecular signals in T cell differentiation. (1981) (16)
Thymuline (FTS) in rheumatoid arthritis. (1984) (16)
Biochemical and biological aspects of the interaction between thymulin and zinc. (1993) (16)
Antigen recognition by T-cells and its suppression. Significance and origin of rosette-forming cells. (1971) (15)
CELL-MEDIATED INHIBITION OF THE TRANSFER OF AUTOIMMUNE DIABETES IN NOD MICE (1989) (15)
Autoimmune diseases, IgA deficiency, and intravenous immunoglobulin treatment. (1992) (15)
In vivo anti-CD3-driven cell activation. Cellular source of induced tumor necrosis factor, interleukin-1 beta, and interleukin-6. (1996) (15)
Prolongation of murine skin grafts by FTS and its synthetic analogues. (1981) (15)
Rosette-forming cells in the unimmunized mouse: morphological studies with phase contrast and electron microscopy. (1971) (15)
Immunological studies in human ageing. II. Associated increase in anti-RNA and anti-DNA antibodies. (1981) (15)
Suppression of the humoral response to anti-CD3 monoclonal antibody. (1989) (15)
monoclonal antibodies raised against Lewy bodies in brains from subjects with Parkinson's disease (1985) (15)
[Linkage between juvenile glaucoma and chromosome 1q in 2 French families]. (1994) (14)
Studies on thymus products. VII. Presence of thymic hormone in urodele serum. (1973) (14)
IN-VIVO ANTI-CD3 TREATMENT OF AUTOIMMUNE PATIENTS (1989) (14)
Association of Km3 allotype with increased serum levels of autoantibodies against muscle acetylcholine receptor in myasthenia gravis (1994) (14)
T-Lymphopenia and T-Cell Imbalance in Diabetic db/db Mice (1986) (14)
Ultrastructure of cells binding immunoglobulin-coated erythrocytes in rheumatoid arthritis. (1974) (14)
ON THE PROPER USE OF BIBLIOMETRICS TO EVALUATE INDIVIDUAL RESEARCHERS (2011) (14)
T cell activation through Thy-1 is associated with the expression of a surface protein (p100) on a subset of CD4 cells. (1995) (14)
Experimental immunoprevention of type I diabetes mellitus. (1991) (13)
Monoclonal antibodies to CD3 as immunosuppressants. (1990) (13)
The wasted mutant mouse. II. Immunological abnormalities in a mouse described as a model of ataxia-telangiectasia. (1986) (13)
Myasthenic sera recognize the human acetylcholine receptor bound to thymopoietin (1987) (13)
Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases. (1994) (13)
Sezary syndrome. I. Specific skin-directed migration of peripheral blood lymphocytes. (1983) (13)
[Biochemical characterization of a circulating thymic factor]. (1976) (13)
Identification by genomic typing of non-DR3 HLA class II genes Associated with Myasthenia Gravis (1993) (13)
Evidence for antigen driven selection in two monoclonal auto-antibodies derived from nonobese diabetic mice. (1993) (13)
The etiology of autoimmune diseases: the case of myasthenia gravis (2012) (13)
Demonstration and characterization of a serum factor produced by activated T cells. (1977) (13)
CD3 antibody-induced IL-10 in renal allograft recipients: an in vivo and in vitro analysis. (1999) (13)
In vitro responses of rat lymphocytes following adult thymectomy. III. Prevention by thymic factor of increased suppressor activity in the spleen. (1972) (13)
Cyclosporine therapy for severe systemic sclerosis associated with the anti-Scl-70 autoantibody. (1990) (12)
New concepts of the etiopathogenesis and treatment of insulin-dependent diabetes mellitus (2000) (12)
Thymoma with hypersecretion of thymic hormone. (1981) (12)
A thymulin analogue peptide with powerful inhibitory effects on pain of neurogenic origin (2003) (12)
Genetics of human type 1 diabetes mellitus. (2001) (12)
The Questionable Role of Anti‐DNA Antibodies in the Pathogenesis of Systemic Lupus Erythematosus (1986) (12)
In vivo soluble tumor necrosis factor receptor release in OKT3-treated patients. Differential regulation of TNF-sR55 and TNF-sR75. (1995) (12)
Cyclosporine in insulin-dependent diabetes mellitus. (1987) (12)
Gene expression of pancreatic glutamic acid decarboxylase in the nonobese diabetic mouse. (1996) (12)
TAP1 and TAP2 transporter genes and predisposition to insulin dependent diabetes mellitus. (1992) (12)
Automation of large-scale HLA oligotyping using a robotic workstation. (1993) (12)
[Current concepts of autoimmunity]. (2002) (12)
Postnatal development of T cells. I. Study of the respective contribution of thymic cellular export, thymic humoral function, and T cell environment. (1979) (12)
Inhibition of Insulin Release In Vitro Mediated by Mononuclear Cells From Diabetic Patients Treated With Cyclosporin A or Placebo (1988) (12)
Major histocompatibility class II genes polymorphism in insulin dependent diabetes mellitus with or without associated thyroid autoimmunity. (1998) (12)
Stimulatory effects of cyclosporin A on human and mouse thymic epithelial cells (1987) (12)
[Anti-beta 2 glycoprotein I antibodies in systemic lupus erythematosus: a marker of thrombosis associated with a circulating anticoagulant]. (1991) (12)
Studies on human thymocytes using anti-T-cell monoclonal antibodies and peanut agglutinin. (1982) (12)
Acquired allo-tolerance to major or minor histocompatibility antigens indifferently contributes to preventing diabetes development in non-obese diabetic (NOD) mice. (1992) (12)
Hypersensitivity to Insulin During Remissions in Cyclosporin-Treated IDDM Patients (1993) (12)
High affinity binding sites on plasma membrane obtained from the lymphoblastoid cultured 1301 cell line for highly radioactive serum thymic factor. (1982) (12)
Cyclosporin-associated nephropathy in patients with autoimmune diseases (1988) (11)
Thymectomy in the young pig: effects on the level of circulating thymic hormone. (1974) (11)
Markers of microbial exposure lower the incidence of atopic dermatitis (2019) (11)
TCR alpha beta gene usage for myelin basic protein recognition in healthy monozygous twins. (1996) (11)
Response of HIV-1-associated polymyositis to intravenous immunoglobulin. (1992) (11)
Impaired Fc alpha receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV-1-infected patients. (1995) (11)
Cutaneous pheomorphic T cell lymphoma. Immunologic, virologic, and T-cell receptor gene rearrangement studies in one European case with initial pseudolymphoma presentation. (1986) (11)
T-cell-directed immunointervention (1993) (11)
Organ-specific autoimmunity. (1995) (11)
The role of class II major histocompatibility complex antigens in autoimmune diabetes: animal models. (1989) (11)
Target cell of thymic hormone. (1973) (11)
Correction: Antibiotics in Early Life Alter the Gut Microbiome and Increase Disease Incidence in a Spontaneous Mouse Model of Autoimmune Insulin-Dependent Diabetes (2016) (10)
Differential in situ expression of cytokine genes in human renal rejection. (1991) (10)
In vivo cyclosporine A treatment inhibits spleen cell mitogen-triggered free [Ca2+] increase. (1988) (10)
In vivo T lymphocyte activation induced in mice following the injection of anti-CD3 monoclonal antibody. (1990) (10)
Antinucleosome antibodies and systemic lupus erythematosus. (1997) (10)
Mechanisms of downmodulation and release of tumour necrosis factor receptor induced by human immunodeficiency virus type 1 in human monocytes. (1997) (10)
Immunological follow-up of renal allograft recipients treated with the BMA 031 (anti-TCR) monoclonal antibody. (1990) (10)
Molecular identification of human T-lymphocyte antigens defined by the OKT5 and OKT8 monoclonal antibodies. (1982) (10)
Anti-β2-Glycoprotein I antibodies and thrombosis (1995) (10)
Cyclosporine in autoimmunity. (1988) (10)
Induction of soluble tumor necrosis factor receptor (sTNF‐R75) release by HIV adsorption on cultured human monocytes (1994) (10)
[Plasma androgens in women with disseminated lupus erythematosus]. (1983) (9)
[Acute clinical syndrome associated with OKT3 administration. Prevention by single injection of an anti-human TNF monoclonal antibody]. (1991) (9)
Autoantibodies in D-penicillamine-induced myasthenia gravis: a comparison with idiopathic myasthenia and rheumatoid arthritis. (1991) (9)
Islet cell antibody heterogeneity among Type 1 (insulin-dependent) diabetic patients (1992) (9)
Nucleotide sequences of variable regions of an human anti-acetylcholine receptor autoantibody derived from a myasthenic patient. (1994) (9)
No evidence for an association of AChR beta-subunit gene (CHRNB1) with myasthenia gravis (1997) (9)
[Analytic study of 69 anti-mouse lymphocyte rabbit serums. II. "In vitro" activity]. (1970) (9)
Idiotypes of monoclonal anti-DNA antibodies produced in autoimmune B/W mice are expressed in normal mice. (1986) (9)
Human IgG monoclonal autoantibodies against muscle acetylcholine receptor: Direct evidence for clonal heterogeneity of the antiself humoral response in myasthenia gravis (1994) (9)
NKT lymphocyte ontogeny and function are impaired in low antibody-producer Biozzi mice: gene mapping in the interval-specific congenic strains raised for immunomodulatory genes. (2000) (9)
In vivo use of OKT3: main issues for the monitoring of treated patients. (1990) (9)
Cellular aspects of myasthenia gravis (1988) (9)
NMR study of thymulin, a lymphocyte differentiating thymic nonapeptide. Conformational states of free peptide in solution. (1986) (9)
Cell-mediated immunity to pancreatic islet cells in the non-obese diabetic (NOD) mouse: in vitro characterization and time course study. (1988) (9)
In vitro modulation of mouse natural killer (NK) cell activity by the serum thymic factor (FTS). (1983) (9)
Binding and blocking antibodies to the human acetylcholine receptor: Are they selected in various myasthenia gravis forms? (1988) (9)
Cytokine-based immunomodulation of autoimmune diseases: an overview. (1996) (9)
In vivo clonal expansion of T lymphocytes specific for an immunodominant N-terminal myelin basic protein epitope in healthy individuals (1995) (9)
Structural and conformational study of the aluminum-thymulin complex using 1-D and 2-D NMR techniques (1988) (8)
Effect of Cyclosporin on Interleukin 2–Related T-Lymphocyte Parameters in IDDM Patients (1989) (8)
Dissociated effects of thymectomy at weaning on T-cell-mediated responses in vitro: correction by the serum thymic factor, FTS, and its analogs. (1981) (8)
The effects of immunomodulation on peripheral T cell subsets. (1982) (8)
[Bird breeder's disease in children. Demonstration of lymphocyte sensitization without delayed hypersensitivity]. (1971) (8)
In vitro and in vivo action of cyclosporin A on the induction of human interleukin-2 receptor alpha and beta chains. (1989) (8)
Production of a lymphocyte differentiating factor (ELDIF) by cultured human epidermal cells. (1985) (8)
The significance of T-cell subsets defined by monoclonal antibodies in human diseases. (1982) (8)
Soluble factors for B cell activation: a T cell hybridoma that secretes a specific B cell growth factor. (1983) (8)
HL-A 1,8 PHENOTYPE AND HBS ANTIGENÆMIA IN HÆMODIALYSIS PATIENTS (1975) (8)
Thymic reticulum of autoimmune mice. II: Ultrastructural studies of mice with lupus-like syndrome (NZB, BXSB, MRL/l). (1990) (8)
[Increase of CXCL10 serum level in systemic sclerosis interstitial pneumonia]. (2009) (8)
Cellular basis of T-cell autoreactivity in autoimmune diseases (1993) (8)
Therapeutic monoclonal antibodies in transplantation. (1993) (8)
[Myasthenia induced by D-penicillamine. Study of immuno-clinical correlations in 23 cases]. (1985) (8)
A new monoclonal antibody recognizing the amino‐terminal consensus sequence of vertebrate intermediate filament proteins (1989) (8)
Recovery from myasthenia gravis of a patient infected with human immunodeficiency virus. (1992) (8)
Immunointervention in autoimmune diseases from cellular selectivity to autoantigen specificity. (1992) (8)
Genetic predisposition to IDDM (2000) (8)
Antigen-Binding Cells (1971) (8)
Selective immunosuppression with anti-T cell monoclonal antibodies. (1992) (8)
Resetting the functional capacity of regulatory T cells: a novel immunotherapeutic strategy to promote immune tolerance (2005) (8)
Detection and characterization of lymphocytes bearing receptors for peanut agglutinin by a specific rosetting technique. (1981) (7)
Autoantibodies to nucleosomes in HIV-1-infected patients. (1994) (7)
Fine-needle aspiration biopsy of human liver allografts. Correlation with liver histology for the diagnosis of acute rejection. (1990) (7)
[Nuclear magnetic resonance study of the interaction of zinc with thymulin]. (1985) (7)
The thymus as an endocrine gland. (1972) (7)
T cell subsets in the blood of rheumatoid arthritis patients in clinical remission. (1982) (7)
[Increase of circulating levels of thymulin in hyperprolactinemia and acromegaly]. (1990) (7)
Reduced incidence of acute, refractory acute, and chronic rejection after liver transplantation with FK506-based immunosuppression. European FK506 Multicentre Liver Study Group. (1994) (7)
Cell-mediated versus humoral immunity in autoimmune diseases and their pharmacologic control with particular reference to type I diabetes mellitus. (1986) (7)
Nonathymulin in rheumatoid arthritis: two double blind, placebo controlled trials. (1987) (7)
Regulation of theta-antigen expression by agents altering cyclic AMP level and by thymic factor. (1975) (7)
Induction of immunological tolerance using monoclonal antibodies: applications to organ transplantation and autoimmune disease. (2006) (7)
HISTURIA DURING RENAL TRANSPLANTATION (1969) (7)
Genetic control of hepatitis A severity and susceptibility to allergy. (2011) (7)
[Early induction of diabetes in NOD mice by streptozotocin]. (1987) (7)
Advances in Nephrology from the Necker Hospital (1986) (7)
Etiology and Pathogenesis of Human Insulin-Dependent Diabetes Mellitus (1999) (7)
Contrasting Effects of Ciclosporin on Humoral and Cell-mediated Immunity in Patients with Autoimmune Diseases (1985) (7)
The new era of immunosuppressive therapy in autoimmune diseases. (1991) (7)
Splenocytes from MRL/Mp-lpr/lpr mice spontaneously produce antibodies against a cell-surface protein cross-reacting with DNA. (1987) (7)
The Pharmacological and Immunological Basis for the Use of Immunosuppressive Drugs (2012) (7)
[Plasma androgens in women with systemic lupus erythematosus]. (1980) (7)
ACTH and Related Peptides (1990) (7)
In vivo T cell activation properties of anti-T cell monoclonal antibodies. (1993) (7)
Autoantibodies against pancreatic beta-cells: characterization by western blot analysis in the non-obese diabetic (NOD) mouse. (1992) (7)
Specificity of acebutolol-induced antinuclear antibodies. (1986) (7)
Strategies in Immunotherapy of Insulin‐Dependent Diabetes Mellitus (1993) (7)
pH and rosette formation. (1972) (7)
Clinical significance of T cell monitoring during antithymocyte globulin induction in renal transplantation. (1997) (6)
Serum thymulin and zinc deficiency in humans. (1987) (6)
Hematopoietic stem cells and myeloid precursor cells in nonobese diabetic (NOD) mice. (1992) (6)
Evaluation of serum thymic hormone and of circulating T cells in rheumatoid arthritis and in systemic lupus erythematosus. (1975) (6)
First and second course of OKT3 monoclonal anti-T cell antibody for treatment of renal allograft rejection followed by testing for anti-OKT3 IgM and/or IgG immunization. (1990) (6)
Allogeneic lymphocyte-dependent antibodies (LDA). Specificity of Fc receptors. (1977) (6)
Aberrant Distribution of CD4 and CD8 Lymphocyte Subsets in Recent-Onset IDDM Patients: Effect of Cyclosporin (1993) (6)
Leucocyte typing versus transformation in mixed lymphocyte culture. (1968) (6)
T lymphocytes in kidney allograft recipients. (1976) (6)
Devising murine models to better adapt clinical protocols: sequential low-dose treatment with anti-CD3 and anti-CD4 monoclonal antibodies to prevent fully mismatched allograft rejection. (1993) (6)
Decreased biological activity of serum thymic hormone (thymulin) in children with nephrotic syndrome. (1984) (6)
Unique role of CD 4 CD 62 L regulatory T cells in the control of autoimmune diabetes in T cell receptor transgenic mice (2004) (6)
Filaggrin gene loss‐of‐function variants modify the effect of breast‐feeding on eczema risk in early childhood (2016) (6)
Epstein-Barr virus serology and isoelectrofocusing pattern of serum immunoglobulins in cyclosporin or placebo-treated type I diabetics. (1992) (6)
Anti-CD3 antibodies. (1993) (6)
Anti-beta 2-glycoprotein I antibodies and thrombosis. (1995) (6)
Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum. (1972) (6)
Establishment of T-cell lines from infiltrated NOD islets by stimulation of specific T-cell receptor V beta segments. (1993) (6)
The Effect of the Serum Thymic Factor (FTS) on Suppressor T Cells (1981) (5)
[Cyclosporin and childhood diabetes: preliminary findings of the Saint Vincent de Paul trial]. (1987) (5)
Autoantibodies ind-Penicillamine treated rheumatoid arthritis (1976) (5)
In vitro characteristics on human lymphocyte functions of a new immunomodulatory agent, a cyclic peptide, cyclomunine. (1980) (5)
Rationale for the Mechanism of Zinc Interaction in the Immune System (2020) (5)
Therapeutic use of monoclonal antibodies in kidney transplantation. (1985) (5)
Thein vivo effects of corticosteroids on thymocyte subsets in myasthenia gravis (1984) (5)
[Phenomenon of e rheumatoid bow. I. New method of detection of the rheumatoid factor at cellular level]. (1970) (5)
Genetic drift in mammals. (2019) (5)
The biological individual--the respective contributions of genetics, environment and chance. (2009) (5)
[Hormonal modulation in disseminated lupus erythematosus: the preliminary results with danazol and cyproterone acetate]. (1986) (5)
[Identification and localization on chromosome 1 of a gene controlling the occurrence of periinsulitis in NOD diabetic mice]. (1991) (5)
Decrease of Thymic Hormone Serum Level in Cockayne Syndrome (1982) (5)
Tolerance and uveitis. (1997) (5)
The therapeutic use of monoclonal antibodies. (1988) (5)
Pathogenesis of IDDM: immune regulation and induction of immune tolerance in the NOD mouse. (1993) (5)
IMMUNOSUPPRESSIVE DRUGS IN DIABETES (1986) (5)
Autoimmune mice develop antibodies to thymic hormone: production of anti-thymulin monoclonal autoantibodies from diabetic (db/db) and B/W mice. (1984) (5)
T cell subpopulations defined by monoclonal antibodies in autoimmune hemolytic anemia. (1983) (5)
[Immunological aging]. (2002) (5)
[Assay of acetylcholine receptor antibodies in myasthenia gravis. A study of 329 sera (author's transl)]. (1982) (5)
[Problems posed by pregnancy in women with lupus nephropathy]. (1983) (5)
[A new test of activity of antilymphocyte serums: inhibition of the rosette phenomenom]. (1968) (5)
[Effect of hormonal contraception on the course of lupus nephropathy]. (1982) (5)
Monoclonal anti-double-stranded deoxyribonucleic antibodies. II. Indirect immunofluorescent studies. (1982) (5)
Deficiency of suppressor/cytotoxic T-cells in idiopathic membranous glomerulonephritis (1980) (5)
Therapeutic strategies in autoimmune diseases: the search for tolerance induction. (1994) (5)
[Acute rheumatic fever in Martinique. Epidemiological, clinical and biological study]. (1986) (4)
Causality in medicine. (2019) (4)
Therapy of Autoimmune Diseases with Monoclonal Antibodies to Class II Major Histocompatibility Complex Antigens: The Role of T Lymphocytes (1988) (4)
Immunosuppression in insulin-dependent diabetes mellitus: from cellular selectivity towards autoantigen specificity. (1995) (4)
Quantitative analysis of glutamate decarboxylase (GAD 65) gene expression in NOD mouse pancreas. (1995) (4)
Immunomodulation of T cells by thymic hormone and monoclonal anti-T cell antibody. (1982) (4)
Thymic hormones and prostaglandins. I. Lack of stimulation of prostaglandin production by thymic hormones. (1989) (4)
Hepatic Homing of Labelled Lymphocytes in Man (1972) (4)
Central venous catheters cvc in aids risk factors for bacterial infection (1990) (4)
Questioning four preconceived ideas on immunotherapy of clinical type 1 diabetes: lessons from recent CD3 antibody trials. (2005) (4)
Studies of the thymus in mice bearing the Lewis lung carcinoma. I. Thymic natural killer cell activity in 3LL tumor-bearing mice. (1983) (4)
Cyclosporin and autoimmune disease (1991) (4)
T‐Cell Receptor Use in Organ‐Specific Human Autoimmune Diseases Other Than Rheumatoid Arthritis and Multiple Sclerosis (1995) (4)
[Renal allograft in dogs treated with antilymphotyce serum. Comparison between "in vitro" tests and immunodepressive effects of the serum]. (1969) (4)
[Assay of anti-acetylcholine receptor antibodies in myasthenic syndromes of newborn infants]. (1986) (4)
Recent advances in the pathogenesis of systemic lupus erythematosus. (1990) (4)
Male BXSB mice develop a thymic hormonal dysfunction with presence of intraepithelial crystalline inclusions. (1989) (4)
Clinical applications of anti-T-cell monoclonal antibodies. (1991) (4)
Thymic hormones--from myth to facts. (1976) (4)
[Immunoregulation and autoimmunity]. (2002) (4)
Autoimmune disorders in diabetes. (1986) (4)
The protective effect of infections on immune disorders. (2005) (4)
BIOLOGICAL ACTIVITIES AND SITE OF ACTION OF THE CIRCULATING THYMIC FACTOR (1979) (4)
Polyclonal and monoclonal antibodies directed against SK & F 94461, a specific H1 histamine receptor ligand. (1988) (4)
Anti-TcR antibodies in autoimmune diseases. (1993) (4)
Stimulation of thymic humoral function by cyclomunine, a cyclic peptide, in mice (1980) (4)
The risk/benefit ratio in immunointervention for autoimmune diseases (1988) (3)
[T CD57+ lymphocytes in kidney transplanted patients. Phenotypic and functional study]. (1992) (3)
Tissue-like proteins excreted in urine from transplanted kidneys (histuria). (1969) (3)
[The rheumatoid rosette (R. R.) phenomenon in chronic evolutive polyarthritis. (C. E. P.). II. Significance; value in the diagnosis of serum-negative cases]. (1970) (3)
In vitro assay for antilymphocyte serum. (1970) (3)
The effects of interleukin-1 on pancreatic beta cell function in vitro depend on the glucose concentration. (1992) (3)
Therapeutic immunosuppression in type I (insulin-dependent) diabetes (1988) (3)
[Prevent and cure insulin-dependent diabetes]. (2003) (3)
The thymus in immunodeficiency diseases: new therapeutic approaches. (1983) (3)
Postnatal development of T cells. II. In vitro migratory properties. (1979) (3)
Preservation of beta cell mass (1990) (3)
Activities of immunosuppressive agents in vitro. 3. Selective alteration of recirculating lymphocytes after in vitro incubation with azathioprine. (1973) (3)
[Determination of active metabolites of immunosuppressive agents in the serum. Application to azathioprine]. (1972) (3)
[T lymphocyte activation induced by monoclonal anti-CD3 antibodies: physiopathology of cytokine release]. (1991) (3)
CHAPTER 36 – Type 1 Diabetes (2006) (3)
The mode of action of thymic hormones and its relevance to T-cell differentiation. (1976) (3)
A simple method for the quantitative evaluation of neuromuscular blockade in mice. (1992) (3)
[Preventive treatment of rejection by the prolonged administration of OKT3: decrease of the immune response of the host]. (1987) (3)
Systemic chimerism in cadaveric kidney allograft recipients. (1995) (3)
[Acute rheumatic fever in New Caledonia. Clinical and epidemiological aspects]. (1986) (3)
A1B8DR3-associated CD8-positive T-cell expansion in HIV infection (1992) (3)
Synthesis of an immunogenic conjugate and of two 125I-labelled derivatives of the "facteur thymique sérique". (1982) (3)
[Immunologic study of subacute infectious endocarditis through the search for circulating immune complexes. Preliminary results apropos of 13 cases]. (1975) (3)
Suppression of the humoral response to anti-CD3 mAB by pretreatment with anti-CD4 mAB. (1989) (3)
Studies on B- and T-cell receptors for lysozyme. (1975) (3)
[Isolated permanent proteinuria: I. Histologic diversity]. (1969) (3)
Isolation of glycopeptide antigenic site from kidney basement membrane. (1971) (3)
Summary of round-table discussion on the technical aspects of the rosette test. (1972) (3)
Study of the complexation of copper (II) with a peptidie hormone from thymus naturally occurring as a zinc (II) complexe (thymulin) (1987) (3)
[Isolated permanent proteinuria. 2. Developmental stability. 3. Nosologic significance]. (1969) (3)
One or several thymic hormones? (1980) (3)
Organ transplantation and autoimmunity: common mechanisms common therapies. (2011) (2)
[Circulating immuns complexes and infections endocarditis. 64 cases (author's transl)]. (1978) (2)
Serum thymic factor (FTS) restores the ability of adult thymectomized mice to be suppressed by hapten-modified self. (1981) (2)
Role of zinc and other metals in the biological activity of serum thymic factor (FTS) (1982) (2)
A clinical trial of antilymphocyte globulin in renal transplantation. Failure to observe a significant improvement. (1972) (2)
COVID-19: individual and herd immunity. (2021) (2)
Chapter 2 CD3 Antibodies as Unique Tools to Restore Self-Tolerance in Established Autoimmunity (2008) (2)
[Inhibition and stimulation by azathioprine of the incorporation of thymidine by lymphocytes in mixed culture]. (1971) (2)
Increased binding of anti-acetylcholine receptor antibodies to thymic antigen in patients with myasthenia gravis and other autoimmune diseases, as compared to those with myasthenia gravis alone (1987) (2)
Thymic hormones and prostaglandins. II. Synergistic effect on mouse spontaneous rosette forming cells. (1990) (2)
Monoclonal antibodies: probes for studying experimental autoimmunity in animals. (1991) (2)
[The appearance of antinucleosome antibodies precedes that of anti-double-stranded DNA and anti-histones in murine lupus]. (1993) (2)
Ultrastructural study of spontaneous bone marrow rosette-forming cells (1977) (2)
Poor tolerance of zidovudine in an HIV-asymptomatic patient with alpha-thalassemia. (1991) (2)
[Pathogenic antibodies in systemic lupus erythematosus: anti-LAMP antibodies]. (1986) (2)
The clinical use of monoclonal anti-t-cell antibodies (1984) (2)
Thymic hormone in the treatment of cancer. (1989) (2)
A dinucleotide repeat and a Hae III polymorphism in the human nicotinic acetylcholine receptor alpha‐subunit gene (CHRNA1) (1997) (2)
Soluble tumor necrosis factor receptors in chronic hepatitis C: a correlation with severity of liver disease (1998) (2)
In vitro correlates of cell-mediated immunity in the human. (1974) (2)
Prospects in the immunological treatment of rheumatoid arthritis. (1984) (2)
Heterogeneity of HLA genetic factors in IDDM susceptibility (2004) (2)
De novo germline mutation in the dual specificity phosphatase 10 gene accelerates autoimmune diabetes (2021) (2)
In situ antigenic modulation of human graft-infiltrating T cells is induced by OKT3 treatment. (1990) (2)
The prospects of immunosuppression in type I diabetes. (1988) (2)
[Heterogeneity of antibodies blocking the binding of bungarotoxin to the acetylcholine receptor in myasthenia]. (1984) (2)
Anti-gamma interferon (IFN-gamma) monoclonal antibodies. (1993) (2)
Mechanisms and significance of HLA type I diabetes association. (1991) (2)
[Thromboembolic manifestations in systemic lupus erythematosus (author's transl)]. (1980) (2)
Causality and complex disease: The example of multiple sclerosis. (2018) (2)
T cell subsets in rheumatic fever in New Caledonia. (1986) (2)
[Role of zinc and other metals in the biological activity of the serum thymic factor (thymulin)]. (1981) (2)
Why is the incidence of autoimmune diseases increasing in the modern world (2008) (2)
Anti-T-Cell Monoclonal Antibodies as Immunosuppressive Agents (1992) (2)
New trends in non-antigen-specific immunosuppression. (1979) (2)
The Non Obese Diabetic (NOD) mouse, as a model of T cell mediated autoimmune disease. (1992) (2)
The majority of mouse spontaneous rosette‐forming cells of thymic origin belong to the Ly‐2+ subset (1989) (2)
Modulation of skin graft rejection in mice by FTS and its analogues (1980) (2)
The multifactorial etiology of autoimmune diseases. (1994) (2)
[Thymic hormones]. (1979) (2)
Activation lymphocytaire T induite in vivo par la première injection de l'anticorps monoclonal OKT3 (1988) (2)
In vitro migration of potential hemopoietic precursors from the murine fetus. (1981) (2)
Synthesis and biological activity of eight thymulin analogues. (1987) (2)
Relevance of Antibodies against the α‐Bungarotoxin Binding Site on the Human Acetylcholine Receptor in Myasthenia Gravis (1987) (2)
Mouse map fills the gap (1992) (2)
Characterization of T cells cultured from fine needle aspirates of human renal allografts during rejection. (1985) (2)
[Inflammation and rejection]. (1990) (2)
New conceptions of autoimmunity and of systemic lupus erythematosus. (1976) (2)
Poor tolerance of zidovudine in an HIV-asymptomatic patient with α-thalassemia (1991) (2)
Increase in plasma 5 alpha-androstane-3 alpha,17 beta-diol glucuronide as a marker of peripheral androgen action in hirsutism: a side-effect induced by cyclosporine A. (1990) (2)
Genetics of autoimmune endocrine diseases (2004) (2)
[Exploration of thymus function in man. 1. Demonstration of a circulating thymic hormone]. (1974) (1)
The serum thymic factor (FTS) (1981) (1)
Hypothesis: systemic lupus erythematosus as a disease secondary to polyclonal lymphocyte activation. (1990) (1)
Early depression of mixed lymphocyte reaction by adult thymectomy. (1972) (1)
HLA Class II polymorphism in insulin dependent diabetes mellitus (IDDM) moroccans (1996) (1)
Potential pathogenic role of cell-surface polypeptides, cross-reactive with DNA, in systemic lupus erythematosus. (1989) (1)
Zinc and Thymulin (1990) (1)
[Renewal of organ transplantation: towards the control of rejection]. (1986) (1)
[Exploration of thymic function in man. II. The "sheep red cell rosette" phenomenon, a T-cell marker in man]. (1974) (1)
The thymus and its role. (1978) (1)
Immunosuppression by chemical agents. (1971) (1)
Role of tap transporter genes in predisposition to insulin dependent diabetes mellitus (1993) (1)
Brazil/France Bilateral Symposium on Biodiversity. (2019) (1)
Control of autoreactive T cell activation by immunoregulatory T cells (ART). (2001) (1)
Myasthenia gravis and hepatitis C virus infection (1994) (1)
Interaction of thymopoietin peptides with the specific receptor of facteur thymique serique (FTS). (1983) (1)
Thymulin: biochemistry, biology and therapeutical applications (1987) (1)
[Can insulin-dependent diabetes be cured or prevented?]. (1992) (1)
Clonality in autoimmune diseases. (1991) (1)
[Periarteritis nodosa and Australia antigen]. (1974) (1)
Functional analysis of lymphocytes recovered from human allograft undergoing rejection. (1987) (1)
[Immunopathology of systemic lupus erythematosus]. (2000) (1)
Chair's introduction. Generation and effector functions of regulatory lymphocytes. (2003) (1)
Susceptibility to celiac disease and peptide transporter genes polymorphism (1993) (1)
IMMUNOREGULATION OF MOUSE NK ACTITVITY BY THE SERUM THYMIC FACTOR(FTS) (1982) (1)
Idiotypic analysis and suppression of autoantibodies to DNA in (NZB X NZW)F1 mice. (1987) (1)
Human T cell clones: edited by M. Feldman, J.R. Lamb and J.N. Woody. Herman Press, Clifton, N.Y., 1985, 455 p., £ 72 (1987) (1)
Role of anti-basement membrane immunity in human glomerulonephritis. (1972) (1)
Forum d'immunologie. XV: Effector mechanisms in type 1 diabetes mellitus (1986) (1)
[Mixed culture of lymphocytes from a newborn with its mother's lymphocytes]. (1971) (1)
Insulin-dependent diabetes: strategy for immune intervention. (2009) (1)
T-cell receptor-based immunointervention in autoimmune diseases. Therapeutic use of monoclonal antibodies. (1993) (1)
Properties of bispecific rosette-forming cells. II. --Rosette formation by "educated" T-lymphocytes. (1975) (1)
Causality and complex disease: The example of multiple sclerosis. (2017) (1)
[Proteinuria in kidney transplantation]. (1967) (1)
Thymic Hormones and Lymphocyte Functions (1988) (1)
[Controlled trial of levamisole in rheumatoid arthritis. Clinical and immunological study of 22 cases (author's transl)]. (1978) (1)
Strategy in Immunosuppression (1992) (1)
A Gene for Hereditary Cerebellar Ataxia to Chromosome Paroxysmal Maps 19P (1995) (1)
Circulating thymic hormones: Laboratory quantitation and clinical significance (1980) (1)
Donor-specific T cell lines grown from fine-needle aspirates of human renal allografts during acute rejection. (1987) (1)
Immunosuppression et infections (1976) (1)
Rheumatoid rosette in juvenile rheumatoid arthritis (1974) (1)
[The genetic determinism of polygenic diseases]. (2005) (1)
Immune regulation by characterized polypeptides : proceedings of an Ortho-UCLA Symposium held in Steamboat Springs, Colorado, January 25-February 1, 1986 (1987) (1)
[Disseminated lupus erythematosus: etiopathogenic factors]. (1977) (1)
Interleukin-2 production and targeting in hemodialyzed patients. (1987) (1)
Thymic Hormones and Rheumatoid Arthritis (1985) (1)
Clinical aspects of immunologic monitoring. (1999) (1)
Ontogeny of thymus factor secretion. (1976) (1)
Corrigendum: A functional variant of SUMO4, a new IκBα modifier, is associated with type 1 diabetes (2004) (1)
Clinical and theoretical interest of the immunochemical analysis of antinuclear antibodies in systemic lupus erythematosus. (1983) (1)
The immunological basis of inflammatory diseases (1984) (1)
Induction of specific unresponsiveness in normal mouse spleen cells by removing the minority of high avidity antigen-binding cells. (1978) (1)
Thymic Factors (Part 2 of 2) (1976) (1)
[In vitro regulation of the secretion of thymulin (STF) by human thymic epithelial cells]. (1983) (1)
Significance of antigen binding by T cells. (1973) (1)
Modulation of autoimmune diabetes by N-ethyl-N-nitrosourea- induced mutations in non-obese diabetic mice (2022) (1)
[Immunological tests in the diagnosis and prognosis of disseminated lupus erythematosus, before treatment (author's transl)]. (1977) (1)
The Immunology of Diabetes: Revolution of Concepts Over a Decade (1999) (1)
[Study of pulmonary lymphocyte populations obtained by alveolar lavage]. (1980) (1)
[Routine application of HLA class II oligotyping. Value of automatization]. (1992) (1)
[Studies on the metabolism of azathioprine]. (1970) (1)
BIOLOGICAL ACTIVITIES OF THE CIRCULATING THYMIC HORMONE (1976) (1)
Two different mechanisms for the inhibition of rosette formation in mice. (1995) (1)
Predictive medicine: from molecular genetics to prevention. Application to insulin-dependent diabetes mellitus. (1992) (1)
Antigen-Galactosylceramide α Autopresents the Marker , Expresses CD 1 d Molecules , and A Subset of NKT Cells That Lacks the NK 1 . 1 (2000) (0)
[Immunosuppressive agents and infection (author's transl)]. (1976) (0)
Autoimmune endocrine diseases: by Anthony P. Weetman, Cambridge University Press, 1991. £27.95, $59.95 (xiv + 260 pages) ISBN 0 521 40161 5 (1992) (0)
[T lymphocyte activation induced in vivo by the first injection of OKT3 monoclonal antibodies]. (1988) (0)
Immunointervention in autoimmune diseases (1989) (0)
[Antibody secreting cellsin immunopathology]. (1970) (0)
In CADASIL-related gen, diagnostic-methods and therapeutic use (1997) (0)
Chantal Kuhn Promoting Immune Tolerance Human CD 3 Transgenic Mice : Preclinical Testing of Antibodies (2011) (0)
[On the proper use of bibliometrics to evaluate physicians and scientists]. (2011) (0)
[Immunochemical characterization of molecules identified in human thymic epithelium by anti-thymulin monoclonal antibodies]. (1985) (0)
Neonatal myasthenia gravis (NMG): Clinical and immunological aspects (1989) (0)
The effect of cyclosporine A on humoral and cellular immunity in insulin-dependent (type I) diabetes mellitus. (1988) (0)
The Wasted Mutant Mouse: a Model for the Study of IgA Deficiency in Ataxia-Telangiectasia (1985) (0)
Thymic and T-Cell Function in Murine and Human Lupus (1983) (0)
[What is the future of the physiopathology and treatment of diabetes?. Interview by P. Youinou]. (1992) (0)
Chair's Introduction (2008) (0)
Recent advances in steroid therapy. (1975) (0)
[Anti-insulin and anti-insulin receptor antibodies: idiotype-anti-idiotype network and regulation of the immune system]. (1986) (0)
The rejection crises in human renal transplantation. (1970) (0)
Growth Hormone and Insulin-Like Growth Factor-I Stimulate Hormonal Function and Proliferation of (1992) (0)
[Long-term course of 32 cases of diffuse proliferative lupus glomerulonephritis, treated with corticoids alone or combined with cyclophosphamide]. (1979) (0)
[Predictive medicine]. (1996) (0)
T-cell receptor use in organ-specific human autoimmune diseases other than rheumatoid arthritis and multiple sclerosis. Summary and overview. (1995) (0)
[Effect of cyclic AMP on spontaneous rosette forming cells]. (1972) (0)
[Progress and difficulties in the concept of immune comples diseases]. (1977) (0)
Forum: introduction to forum on GAD (2003) (0)
[Significance of the rosette phenomenon in non-immunized mice]. (1969) (0)
On the Stability of T Cell Differentiation Antigens (1984) (0)
A sensitive elisa assay for detection of anti-ACHR antibodies in myasthenia gravis (1991) (0)
[The present and the future of immunomodulators]. (1982) (0)
The Immunological Basis of the Treatment of Glomerulonephritis (1981) (0)
[Production of monoclonal autoantibodies inhibiting the secretion of insulin by the islets of Langerhans]. (1984) (0)
[Therapeutic use of immunostimulants against infections (author's transl)]. (1980) (0)
SP0012 THE HYGIENE HYPOTHESIS IN AUTOIMMUNITY (2019) (0)
Immunopathology of Insulin-Dependent Diabetes Mellitus (IDDM) (1994) (0)
Nucleotide sequence encoding a flavin monooxygenase, corresponding protein composition and intended for the diagnosis and therapy of glaucoma (1996) (0)
[Cross-reactivity between major histocompatibility complex class II antigens in mice NOD and an islet antigen with 58 kDA molecular weight]. (1989) (0)
WITHDRAWN: Immunoregulatory responses induced through TLRs and potential therapeutic implications for autoimmune diseases. (2008) (0)
[Absence of thymus hormone in the serum of NZB and NZBXNZW mice and patients with systemic lupus erythematosus]. (1972) (0)
Postnatal Development of T Cells (1979) (0)
A strategy for prediction of peptide binding affinity for the human peptide transporter (1996) (0)
THYMULIN ANALOGUES FOR PROBING SPECIFIC BINDING SITES ON LYMPHOBLASTOID CELLS (1987) (0)
NMR STUDY OF THYMULIN, A THYMIC NONAPEPTIDE HORMONE. INFLUENCE OF Zn(II) COMPLEXATION ON THE CONFORMATIONAL PROPERTIES (1987) (0)
Perspective Summary of Brief Report on Thyroid Disease of Post Glaciations Quaternary Is Endocrinology of Ecology System in Centre Marc Sankale Setting in Dakar (2020) (0)
Pathway the LFA-1 / Intercellular Adhesion Molecule-1 Autoimmunity upon Transient Blockade of Long-Term Reversal of Established Chatenoud and (2002) (0)
[Immunological tests as guide-lines for the treatment of systemic lupus erythematosus (author's transl)]. (1980) (0)
[Metabolic and immunologic effects of cyclosporine administration in new insulin-dependent diabetics]. (1985) (0)
Microbiome and Autoimmunity (2014) (0)
[Lupus associated membrane protein. Changes in the sensitivity of proteases during the life span of mice with lupus]. (1987) (0)
[In vivo induction of antigenic modulation in man by an anti-T cell monoclonal antibody (author's transl)]. (1982) (0)
Aetiology and pathogenesis of insulin-dependent diabetes mellitus (IDDM) (1998) (0)
[Hypertension induced by cyclosporin A in insulin-dependent diabetic patients. A one-year follow-up]. (1990) (0)
[Functions of the thymus epithelium]. (1985) (0)
Immunologic Disturbances of Receptors in Diseases (1983) (0)
Cellular Levels of Expression of Genes Coding for Organspecific Autoimmune Diseases (1993) (0)
[Erythrocyte phenotype in acute rheumatic fever]. (1987) (0)
[The rheumatoid rosett test in rheumatoid polyarthritis in children. Its value in incomplete forms]. (1971) (0)
[New method of detecting the rheumatoid factor at the cellular level]. (1968) (0)
[Evolution of the concept of autoimmunity and its therapeutic implications]. (1989) (0)
The circulating thymic factor. Isolation, biochemical character- istics, and role in the control of autoimmunity. (1975) (0)
Immunogenicity of foreign tissues: comment. (1980) (0)
[New concepts of the etiopathology of autoimmune diseases]. (1980) (0)
Thymopoietin: A marker of the human nicotinic acetylcholine receptor (H.AChR) (1987) (0)
Antigen recognition by T lymphocytes. V. Life span of mouse spontaneous rosette-forming cells. (1974) (0)
[Recognition of antigen in vivo by cells forming spontaneous rosettes]. (1970) (0)
Summary: Symposium on Lymphocyte Activation. (1990) (0)
[Demonstration of a thymic hormone in serum]. (1972) (0)
Specificity of Metal Binding to Serum Thymic Factor (FTS) (1984) (0)
[Principles of immunologic therapy. Elements for a new strategy]. (1980) (0)
Cyclosporin A in insulin-dependent diabetes (1989) (0)
[Introduction to the clinical use of immunosuppressive agents]. (1974) (0)
[Definition and evaluation of immunosuppressive agents]. (1972) (0)
[Antilymphocyte serum. I]. (1970) (0)
[A new specificity for anti-DNA antibodies]. (1984) (0)
Retroviral Gene Therapy Nonobese Diabetic Mice by an IL-4-Based Mediating Active Tolerance Is Potentiated in The Activity of Immunoregulatory T Cells (2001) (0)
Effector Mechanisms of Autoimmune Diseases (1988) (0)
ALLOGENEIC LYMPHOCYTE‐DEPENDENT ANTIBODIES (LDA) (1977) (0)
The Target Cell of Immunosuppressive Agents (1976) (0)
[Acute rheumatic fever, a disease still present in developing countries]. (1986) (0)
Sera from type I diabetes patients promote abnormal stimulation of B cell insulin release (1990) (0)
442 Prieur , Bach , Griscelli , Judet , Ballet , Bach , and Mozziconacci (0)
MRL-Treatment of Lupus Autoimmune Disease in Granulocyte-Colony Stimulating Factor (1999) (0)
[Cellular basis of antibody production. 1. Recognition of the antigen]. (1972) (0)
Evidence for a specific zinc-dependent conformation of thymulin, a thymic hormone (1985) (0)
[The mode of action of immunosuppressors]. (1974) (0)
Systemic chimerism in long-term cadaveric kidney allograft recipients (1994) (0)
[Immunologic factors in arterial pathology]. (1981) (0)
[Toxicity and secondary effects of antilymphocyte serums]. (1969) (0)
[Modification of the antigenicity of the serum thymic factor (thymulin) by zinc]. (1981) (0)
Recent Data on the Structure, Localization and Function of the Serum Thymic Factor (Thymulin) (1984) (0)
[Monoclonal antibodies. Diagnostic and therapeutic use and prospects for the future]. (1993) (0)
Thymic NK activity in 3LL tumor-bearing mice: Modulation by thymulin (FTS-Zn) (1982) (0)
Tolerance induction in transplantation and autoimmune diseases. (1995) (0)
[Immunology of insulin-dependent diabetes. Towards practical applications]. (1992) (0)
Cyclosporine for Type I Diabetes: Lessons from First Clinical Trials and New Perspectives (2019) (0)
Monoclonal anti-dna antibodies. Abstr. (1981) (0)
[Mechanisms of autoimmunity]. (1987) (0)
In vitro regulation of NK activity by FTS (1982) (0)
Molecular Basis for Induction of Tolerance in Type I Diabetes (2007) (0)
[Immune deficit and autoimmunity]. (1977) (0)
The challenges facing scientific edition (2014) (0)
[Treatment of severe systemic lupus erythematosus. Long-term results in 55 patients (author's transl)]. (1980) (0)
Effects of the Duration and Control of Insulin-Dependent Diabetes mellitus on the Dental Caries Status of Diabetic Children and Adolescents (1998) (0)
[Type 1 diabetes mellitus, autoimmune disease: physiopathologic aspects and practical applications]. (1991) (0)
La medecine predictive. Discussion (1996) (0)
[Immunological origin of autoimmune cytopenias]. (1992) (0)
[Cellular and genetic basis of endocrine diseases of auto-immune origin]. (1982) (0)
[What can one expect of immunostimulants in the clinical setting?]. (1986) (0)
[In vivo use of OKT3 monoclonal antibodies in recipients of renal allografts]. (1987) (0)
[Histuria during renal transplantation in man]. (1969) (0)
[From the XVIII Century (le Siècle des Lumières) and the Veterinary School creation until now: 250 years of fighting epizootics]. (2012) (0)
The use of certain immunosuppressive drugs in the clinical study of gout. (1974) (0)
[Biology at Académie des sciences]. (2020) (0)
Use of IL-7 in the treatment of autoimmune diseases, especially diabetes mellitus insulin (1996) (0)
[Studies on the origin of cells forming spontaneous rosettes]. (1971) (0)
[Anti-idiotypic auto-antibodies of anti-DNA antibodies in disseminated lupus erythematosus]. (1989) (0)
Immunoregulatory cells: potential role in multiple sclerosis and other autoimmune diseases (1992) (0)
Lessons for transplantation of cyclosporine experience in the treatment of autoimmune diseases (2001) (0)
[Cyclosporin and autoimmune diseases. 1: Experimental bases]. (1987) (0)
Proceedings ofPhysiology and Disease, a Symposium Held at the Pasteur Institute, 13–15 November 1995. Preface (1996) (0)
New thymic polypeptides or antagonistic activity and process for their manufacture (1978) (0)
[Therapeutic use of monoclonal antilymphocyte antibodies]. (1983) (0)
Immunotherapy of autoimmune diseases. (1988) (0)
Clinical Pharmacology of 0KT3 (1988) (0)
[Changing concepts of disseminated lupus erythematosus]. (1980) (0)
[Production of human antitetanus antibodies by hybridomas]. (1983) (0)
[Demonstration of 2 low molecular weight factors, 1 secreted by the thymus gland, the other by activated T cells, conferring theta antigen to theta negative lymphocytes]. (1974) (0)
Thymus-dependency of antiinfectious defence: lessons from the study of immunosuppressed individuals. (1988) (0)
Unique features of human and monkey xenosensitization against anti-T cell murine monoclonals (1985) (0)
Antireceptor or antihormone autoimmunity and its relationship with the idiotype network. (1987) (0)
[Demonstration of a population of lymphocytes particularly sensitive to certain immunosuppressors]. (1969) (0)
[Proteinuria of transplanted kidneys]. (1967) (0)
[A correlation between histocompatibility antigens HL-A 1 and 8 and an improved defense in the chronic uremic patient against hepatitis B virus]. (1975) (0)
[Ultrastructure of cells forming "spontaneous rosettes" in mouse spleen]. (1970) (0)
[Autoantibodies and immune complexes in immunopathology. Pathogenic effects and diagnostic value]. (1980) (0)
Early affect of adult thymectomy. (1971) (0)
[Antilymphocyte serum. II]. (1970) (0)
[Arterial hypertension]. (1969) (0)
[Screening of pre-diabetes type I: possibilities and limits]. (1992) (0)
[The rosette technic. Immunologic significance and clinical applications]. (1972) (0)
Letter: Absence of demonstrable effects of thymocytotoxic antibodies on serum thymic hormone level in NZB mice. (1976) (0)
International symposium on antilymphocyte serum : proceedings of the 26th symposium organized by the permanent section of microbiological standardization and held at the palais des Congrès, Versailles March 23-25, 1970 (1970) (0)
Preface: Immunology of Diabetes 95: 14th Immunology of Diabetes Workshop held at Orvieto, Italy, 31 October–3 November 1995 (1996) (0)
[Proceedings: Double rosette-forming cells]. (1975) (0)
Induction of remission of insulin-dependent diabetes by cyclosporin (1987) (0)
[History of lymphocytes]. (1993) (0)
1598 – THYMIC FACTORS (1978) (0)
IMMUNOREACTIVITY AND BIOLOGICAL ACTIVITY OF THYMULIN ANALOGS STUDIED BY EIA AND ROSETTE ASSAY (1987) (0)
[Renal transplantation crisis]. (1970) (0)
Use of peptide analogues of thymulin (pat) for the manufacture of medicaments against pain (2001) (0)
[Neuro-immunology. A new branch of neurology]. (1986) (0)
Appearance of T-celi Markers in Bone Marrow Rosette-Forming Cells after Incubation with Thymosin , a Thymic Hormone ( cell-mediated immunity / B-cells / azathioprene / thymectomy / anti-lymphocyte serum / anti-theta serum ) (0)
Characterization of T Cells Cultured From Fine Needle Aspirates of Human Renal Allografts During Rejection (1985) (0)
[Treatment of lupus: the point of view of the immunologist]. (1990) (0)
[Cellular basis of antibody production. 2. Cellular cooperation]. (1972) (0)
Immunologic problems and perspectives in the therapeutic use of monoclonal antibodies in nephrology. (1985) (0)
The Therapeutic Use of Anti-CD3 Monoclonal Antibodies in Autoimmune Diseases-Application to Type I Insulin-Dependent Diabetes (1994) (0)
[French biological research: the excellence is there, and the next generation ready to take over]. (2009) (0)
Polyclonal B cell autoreactivity in the autoimmune NOD mouse (1990) (0)
Utilisation clinique des anticorps anti-lymphocytes T (1990) (0)
Therapeutic anti-T-cell monoclonal antibodies (2001) (0)
A New Approach to Immunostimulation: Thymic Factors (1979) (0)
[Detection of pre-diabetes in France. French Diabetes Detection Group]. (1997) (0)
[Detection of antiglomerular and antitubular basement membrane antibodies in kidney diseases by means of passive hemagglutination]. (1971) (0)
[Immunoendocrinology. Introduction]. (1986) (0)
Clinical use of thymulin (FTS-Zn) in immunodeficiency syndromes (1982) (0)
[Present and future value of monoclonal antibodies in nephrology]. (1985) (0)
[The cellular basis of antibody production. 3. Differentiation of lymphocytes and antibody production]. (1972) (0)
Immunology of endocrine diseases., 1 vol, A.M. McGregor. MTP Press Ltd, Lancaster (1986), 202+xii, (16 x 24 cm) (1987) (0)
[Recent studies on graft immunology]. (1977) (0)
[Immunological response of the recipient of a renal allograft]. (1973) (0)
Essential Clinical Immunology: Immunological Aspects of Endocrine Disease (2009) (0)
[The acquired immunodeficiency syndrome, a new disease of uncertain future]. (1986) (0)
[Immunosuppressive agents in the preventive treatment of the rejection of kidney grafts]. (1969) (0)
Letter: Self and not-self. (1974) (0)
Impaired Fc&agr; receptor expression is linked to increased immunoglobulin A levels and disease progression in HIV‐1‐infected patients (1995) (0)
[New pathogenetic concept of systemic lupus erythematosus. Immunogenic role of a cell surface protein? Clinical and therapeutic implications of lupus]. (1986) (0)
[Reduction in thymic hormone in subjects with signs of premature aging (Cockayne's syndrome)]. (1977) (0)
[Immunotherapy of type 1 diabetes]. (1992) (0)
Is there a pathology of thymic hormone production (1986) (0)
[Cancer in immunosuppressed patients. Ransom of effectiveness, avoidable risk]. (1991) (0)
REPORT ON THE WORKSHOP: “DIFFERENTIATION OF T-CELLS AND THEIR MEMBRANE DETERMINANTS” (1976) (0)
Diabetes in B-cell depleted NOD mice (1990) (0)
Analyzing Casein-Specific IL-4 and IL-13 Secreting T-Cells: A Reliable Tool For Diagnosis Of Cow's Milk Allergy (2014) (0)
Signals of T-cell hemopoiesis (1986) (0)
O820 – Presentation of an autoantigenic (GAD65) peptide in IDDM by an HLA allele protecting from disease (1996) (0)
[Sandoz-INSERM randomized trial of cyclosporine in type I insulin-dependent diabetes]. (1985) (0)
[Differentiation and physiology of T lymphocytes]. (1988) (0)
[Cyclosporin and autoimmune diseases. 2: Human autoimmune diseases]. (1987) (0)
[Cancer immunotherapy: from fundamental concepts to clinical applications]. (1992) (0)
[Cardiovascular risk, cholesterol and statins]. (2013) (0)
[Immunological expectations at the dawn of the XXIth century]. (2004) (0)
[Systemic lupus erythematosus. Physiopathology, diagnosis, development and prognosis]. (1988) (0)
De novo germline mutation in the Dual Specificity Phosphatase 10 gene accelerates autoimmune diabetes in Non-Obese Diabetic (NOD) mice (2021) (0)
T cells and insulin-dependent diabetes mellitus (1995) (0)
Gene involved in cadasil, diagnostic method and therapeutic application (1997) (0)
2138 Exclusion of chromosome 1q as the susceptibility locus in familial primary open angle glaucoma (1995) (0)
[Contribution of immunology to the early diagnosis of insulin-dependent diabetes]. (1987) (0)
[Detection of circulating immune complexes by three techniques using polyethylene glycol (author's transl)]. (1977) (0)
FUTURE GOALS FOR THERAPEUTIC MONOCLONAL ANTIBODIES (1995) (0)
O644 - Relationship between TH1 and TH2 type cytokines and HLA-linked genetic control of hepatitis B vaccine response (1996) (0)
Genetic and environmental factors in Systemic lupus erythematosus (1994) (0)
Immunosuppression in organ transplantation: past, present, and future. (1980) (0)
Encephalomyelitis Established Experimental Autoimmune Unresponsiveness and Functional Reversal of T Cell + Monoclonal Antibody Induces CD 4 Treatment with Nonmitogenic Anti-CD 3 (2005) (0)
[The action of D-penicillamine on the distribution of T and B-lymphocytes in rheumatoid arthritis]. (1977) (0)
[Horse anti-dog-lymphocyte serum]. (1970) (0)
[Congenital nephrotic syndrome. Immunologic study]. (1969) (0)
[Immune deficiency and Kaposi's disease in 2 young male homosexuals]. (1982) (0)
Thymopoietin, a thymic hormone as cofactor of pathogenic antibodies in myasthenia gravis (1991) (0)
[1972 Nobel Prize in medicine. The structure of antibodies]. (1972) (0)
Response to the Comment by D. Bresson and M. von Herrath (2005) (0)
Using fragments fc human immunoglobulin g, of analogous peptides of the Fc fragment or immunoglobulin g human in obtaining a preparatory medicament for administration to man for therapeutic or diagnostic purpose, of monoclonal antibody (1988) (0)
HLA class II DNA polymorphism in a Moroccan population from the Souss , Agadir area IZAABEL (2017) (0)
Polypeptide having thymic effectiveness (1975) (0)
[Etiologic factors of disseminated lupus erythematosis]. (1976) (0)
CONTRIBUTION OF MONOCLONAL ANTI-T CELL ANTIBODY IN THE FOLLOW-UP AND THE IMMUNOSUPPRESSIVE TREATMENT OF RENAL TRANSPLANT PATIENTS (1984) (0)
[Can one measure in vitro the efficacy and toxicity of antilymphocyte serum?]. (1970) (0)
[Immunosuppression trials in type I diabetes]. (1987) (0)
T cell selective immunointervention in humans (1986) (0)
Immunoregulatory cells: Potential role in MS and other autoimmune disease (1991) (0)
[Therapeutic monoclonal antibodics]. (2006) (0)
[Are anti-DNA antibodies truly directed primarily against DNA?]. (1985) (0)
Techniques for Characterization of Leucocyte Antigens and Utilization of Antibodies in Therapy (1984) (0)
On the extrapolation from animal models to human disease for the design of immunotherapy in autoimmune diabetes (2003) (0)
in the two low-dose groups in the Protégé teplizumab study) proved ineff ective. (2011) (0)
[T-lymphocyte subpopulations in chronic inflammatory rheumatism]. (1982) (0)
Change of Editorship (2006) (0)
P360 – Linkage disequilibrium between HLA class II (DR,DQ,DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex (1996) (0)
Using thymulinähnlichen peptides for production of pain-forward (2002) (0)
Renal Manifestations in the Antiphospholipid Syndrome (2018) (0)
New Concepts in the Etiopathogenesis of Systemic Lupus Erythematosus (1989) (0)
[Analytic study of 69 anti-mouse lymphocyte rabbit serums. I. "In vivo" activity]. (1970) (0)
[Editorial: The thymus, key organ of immunity]. (1974) (0)
[Nephrotic syndrome]. (1968) (0)
[Immunopathology of arterial diseases (author's transl)]. (1980) (0)
Mechanisms of Action of Drugs Affecting Immune Responses (1972) (0)
[Extention of the concept of antireceptor autoantibody disease]. (1982) (0)
[Increase in activity of natural killer cells (NK cells) by serum thymic factor]. (1979) (0)
[Characterization of a specific receptor of the serum thymic factor in a human T-lymphocyte line]. (1979) (0)
Letter: HL-A 1,8 phenotype and HBs antigenaemia in haemodialysis patients. (1975) (0)
Antigen-binding lymphocytes. (1970) (0)
Properties of bispecific rosette-forming cells. I.--Presence of T-lymphocyte markers. (1975) (0)
[A new medical discipline: clinical immunology]. (1980) (0)
[What are we learning about spontaneous insulin-dependent diabetes in laboratory animals?]. (1988) (0)
Abstract of the European conference on histocompatibility 1994Polymorphism of the DQB1 promoter region in insulin dependent diabetes mellitus (1994) (0)
In vivo evidence that L3T4+ T cells recruit Lyt-2+ T cells to mediate beta cell destruction in the autoimmune NOD mouse (1990) (0)
Properties of bispecific rosette-forming cells. III.---Antigen binding cells with double specificity after immunization with two covalently linked antigens. (1976) (0)
Rheumatoid rosettes (significance of the phenomenon). (1970) (0)
Mode of Action of Thiopurines (1992) (0)
[Presentation of a case of dermatomyositis]. (1977) (0)
[Introduction on the mechanism of graft rejections]. (1977) (0)
[Antigenic markers of immunocompetent cells in rheumatoid synovial membrane]. (1983) (0)
[Systemic lupus erythematosus. Ethnic characteristics and geographic origin in 118 patients]. (1983) (0)
Cerebral Autosomal Dominant Arteriopathy withSubcortical Infarcts andLeukoencephalopathy, Genetic Homogeneity, andMapping of theLocuswithin a 2-cMInterval (1996) (0)
Stimulatory effects of cyclosporin and mouse thymic epithelial cells (1985) (0)
[Immune complexes in disseminated lupus erythematosus]. (1976) (0)
[Diabetes caused by insulin-receptor antibodies. Autoimmune diabetes caused by anti-islands of Langerhans immunity]. (1986) (0)
[AIDS and other acquired T cell immunodeficiency syndromes]. (1988) (0)
Influence of oral contraceptive therapy on lupus nephropathy (authors transl) (1982) (0)
Notice of retraction. (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Jean‐françois Bach?

Jean‐françois Bach is affiliated with the following schools:

University of Florida

Jean‐françois Bach's Academic­Influence.com Rankings

Jean‐françois Bach's Degrees

Why Is Jean‐françois Bach Influential?

Jean‐françois Bach's Published Works

Published Works

What Schools Are Affiliated With Jean‐françois Bach?

Jean‐françois Bach's AcademicInfluence.com Rankings